TSS:Rfhg 221897.1

Basic information about the TSS

---

TSS ID: rfhg_221897.1 TSS ID(Version3): hg_185212.1 hg_185211.1 Species: human Chr: chr20		Start: 50190815 End: 50190902 Strand: +
Source datasets	FANTOM5|PRJNA4843412|DRA013844|PRJNA401781|PRJNA548673 |PRJNA615891
Protocol	CAGE|NETCAGE|ReCappable-seq|SLIC_CAGE|TIF-seq2
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3308560,EH38E2119489)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000303004.5:0 AK291536:0 BC021931:0 AF289608:0 BC007538:0 GeneID: 1051 HGNC/MGI_ID: HGNC:1834 UniProt_ID: P17676 Nearer transcript ids and distances:

Gene_name: CEBPB Gene_symbol: CEBPB Gene_synonyms: C/EBP-beta CRP2 IL6DBP LAP NFIL6 Gene_source: HGNC:1834

TATA-Box annotation

---

Distance to TSS:	28
Nearest PromoterID:	NM_005194
Entrez ID:	1051
Nearest Unigene:	Hs.517106
Nearest Refseq:	NM_005194
Nearest Ensembl:	ENSG00000172216
Gene Name:	CEBPB
Gene Alias:	C/EBP-beta|IL6DBP|NF-IL6|TCF5
Gene Type:	protein-coding
CpG%:	0.057471
GC%:	0.636364
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CEBPB p2@CEBPB p3@CEBPB p4@CEBPB p5@CEBPB p6@CEBPB p7@CEBPB p8@CEBPB p9@CEBPB p10@CEBPB
Sample		p1@CEBPB	p2@CEBPB	p3@CEBPB	p4@CEBPB	p5@CEBPB	p6@CEBPB	p7@CEBPB	p8@CEBPB	p9@CEBPB	p10@CEBPB
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	64.48	13.25	0.97	0.00	0.19	0.78	0.39	0.78	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	72.83	13.35	1.01	0.20	0.40	0.20	0.20	0.61	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	61.34	10.61	0.58	0.00	0.39	0.19	1.16	1.54	0.58	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	95.85	10.40	0.21	0.00	0.00	0.83	0.42	1.04	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	104.16	9.00	0.67	0.22	0.22	0.22	1.12	1.80	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	92.45	11.05	0.78	0.00	0.78	0.58	0.58	1.36	0.58	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	83.67	13.29	1.09	0.22	0.87	0.87	0.22	1.74	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	104.64	8.24	0.97	0.24	0.24	0.48	0.48	1.94	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	109.42	10.47	1.50	0.21	0.43	0.43	0.43	1.07	0.43	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	392.41	24.92	3.48	0.00	1.16	2.32	0.00	2.90	3.48	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	393.32	18.19	1.21	0.00	1.21	0.81	0.00	6.06	0.81	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	361.83	17.08	3.25	0.41	0.41	1.22	1.22	7.72	2.03	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	150.39	14.99	1.45	2.10	0.97	1.93	1.77	0.97	0.64	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	115.47	12.48	0.90	1.50	0.90	2.10	2.10	0.45	1.35	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	105.61	8.34	1.10	1.54	1.10	1.54	1.32	0.66	1.54	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	144.61	12.57	0.50	0.50	0.50	5.78	1.51	0.75	0.75	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	120.12	11.58	0.87	1.75	0.22	3.06	1.53	1.09	1.09	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	141.73	13.50	1.27	1.27	0.84	2.11	1.27	0.84	1.27	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	185.54	10.66	2.67	3.20	1.60	3.73	1.07	0.00	2.13	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	229.27	12.94	1.96	1.65	1.50	3.31	2.26	1.50	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	238.43	14.57	2.00	2.94	1.34	3.88	2.81	1.07	2.14	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	284.83	18.64	4.32	2.07	0.69	6.56	2.24	1.21	2.07	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	218.83	15.77	3.88	2.71	1.94	4.01	1.68	1.68	1.94	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	244.37	16.99	2.18	3.15	0.49	3.88	1.70	0.73	1.94	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	300.56	20.64	2.32	3.61	2.32	5.68	1.03	2.06	3.61	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	342.15	23.11	5.06	3.17	1.90	3.17	2.85	3.80	3.48	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	282.97	20.88	2.20	2.20	0.55	6.04	0.00	3.30	2.20	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	505.45	24.99	6.84	4.95	3.06	4.24	2.83	5.42	3.06	4.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	485.38	31.98	5.65	5.17	2.26	5.81	2.91	3.39	2.91	4.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	390.89	32.21	3.98	5.25	2.17	4.34	2.71	2.71	2.90	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	367.61	33.29	6.70	4.81	1.26	5.44	1.88	1.67	4.19	3.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	406.39	28.33	3.71	2.54	1.76	7.42	1.56	2.54	3.91	3.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	445.06	38.20	6.33	4.85	2.74	8.23	1.27	0.63	4.22	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	278.09	32.49	3.46	1.65	1.98	4.29	0.49	1.48	2.64	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	351.73	34.78	4.86	5.24	2.43	8.41	2.62	1.87	3.74	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	351.25	24.91	4.60	4.60	1.72	4.79	3.64	1.53	4.02	4.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	213.37	27.59	1.64	2.66	1.43	3.07	2.45	1.84	1.64	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	189.60	17.53	2.42	3.02	1.21	3.22	1.01	1.01	2.01	3.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	190.69	23.77	1.89	1.89	2.16	3.51	1.62	1.35	2.97	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	116.19	15.36	0.24	1.92	0.96	0.96	1.68	0.48	1.44	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	131.04	16.47	0.47	1.18	1.18	1.65	1.65	0.71	0.71	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	105.26	17.71	1.02	0.59	0.59	2.93	0.73	0.44	0.73	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	103.76	12.86	0.84	0.63	1.90	2.32	0.63	0.21	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	126.57	13.64	2.10	1.22	1.22	2.80	1.75	0.87	1.40	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	108.02	15.86	1.20	0.60	1.41	1.41	0.60	0.60	0.60	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	131.91	14.66	2.09	1.40	2.33	1.40	2.79	0.23	1.40	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	136.27	20.87	0.72	0.72	1.20	1.92	2.40	1.20	0.24	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	161.84	18.18	1.19	0.89	0.89	1.79	1.49	1.19	1.19	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	212.80	21.78	1.20	2.15	0.96	1.68	2.87	1.20	0.96	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	189.05	23.45	1.21	2.02	1.21	3.64	3.03	0.61	2.02	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	141.83	19.27	1.43	2.05	1.23	3.69	0.61	1.23	2.46	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	173.23	25.57	1.11	2.22	0.89	3.56	2.00	0.67	2.22	4.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	27.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	123.85	14.55	1.42	1.77	0.71	2.13	1.42	0.00	1.77	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	113.66	12.26	0.66	0.66	1.66	0.99	0.99	0.66	0.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	79.70	15.10	0.00	0.00	0.84	4.19	0.00	0.84	3.36	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	73.94	14.24	1.38	0.46	0.46	4.59	1.38	0.46	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	76.81	14.26	0.32	0.00	0.65	2.92	1.62	0.00	0.65	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	77.72	8.03	1.28	0.32	0.96	0.96	1.61	0.00	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	60.98	16.66	0.00	0.00	1.26	3.46	0.00	0.00	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	62.04	10.58	0.00	0.71	1.41	0.71	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	77.39	8.97	2.24	0.56	0.00	1.68	1.12	0.00	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	49.36	14.33	2.39	0.00	0.80	2.39	0.80	0.00	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	54.02	13.93	0.68	0.00	0.68	3.74	2.38	0.34	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	56.54	8.45	0.97	1.62	3.25	0.97	0.65	0.97	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	48.28	11.36	0.71	1.06	1.77	0.35	3.90	0.71	1.06	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	32.33	0.00	0.00	0.00	32.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	15.79	0.00	0.00	0.00	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	38.51	7.31	0.00	0.49	1.95	0.49	0.98	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	34.22	8.93	0.00	1.49	1.98	0.50	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	30.49	10.32	0.47	0.00	1.41	0.47	2.35	1.41	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	29.81	13.25	0.33	0.00	0.99	0.00	0.33	0.66	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	38.98	10.52	0.00	0.62	2.17	0.93	0.62	0.00	0.31	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.05	12.84	0.00	0.61	1.83	0.31	1.83	0.31	0.31	0.92
Adipocyte - breast, donor1	11376-118A8	261.81	22.81	3.01	1.43	2.38	4.12	1.27	0.63	2.38	0.63
Adipocyte - breast, donor2	11327-117E4	280.75	27.91	2.73	2.73	2.41	4.49	1.44	1.28	1.76	1.28
Adipocyte - omental, donor1	11473-119C6	343.90	23.92	5.47	3.31	2.16	4.20	1.02	2.16	3.56	1.91
Adipocyte - omental, donor2	11474-119C7	225.74	18.69	2.24	1.49	0.00	2.99	0.75	1.49	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	257.55	21.77	3.01	2.34	2.68	4.02	1.34	0.33	1.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	165.24	15.31	1.28	1.91	1.28	1.28	0.64	1.91	0.00	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	153.93	28.59	2.20	0.00	1.10	2.20	0.00	2.20	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	241.17	17.16	4.52	0.45	1.81	3.61	0.45	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	185.77	21.72	2.09	2.78	2.26	0.35	0.17	0.52	1.22	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	463.70	21.71	3.72	2.74	1.17	4.89	0.98	0.98	2.74	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	442.95	11.84	3.86	5.15	1.03	4.12	1.80	0.77	4.89	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	262.88	25.09	3.62	0.84	1.67	1.39	0.56	0.56	1.39	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	333.88	25.28	5.29	4.11	0.00	1.18	0.59	1.18	4.11	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	317.71	24.29	4.67	4.10	2.17	3.38	0.72	0.88	1.93	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	293.38	20.98	5.49	2.26	0.65	3.23	0.32	0.32	4.84	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	166.35	17.60	4.27	1.07	0.53	1.07	0.53	0.53	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	245.94	16.69	6.12	4.45	0.56	0.00	2.78	1.11	2.23	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	328.55	34.52	5.82	5.41	2.91	2.91	0.83	0.83	2.50	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	317.47	24.11	6.28	2.01	1.51	4.27	0.50	1.00	2.26	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	245.76	21.27	3.93	1.96	1.96	1.31	0.98	1.31	2.29	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	172.03	17.35	4.87	2.74	0.61	1.22	0.91	0.61	3.35	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	234.70	21.88	1.77	1.55	1.10	0.66	0.22	1.10	1.33	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	253.88	31.91	1.43	1.43	1.79	1.08	1.43	1.08	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	265.96	27.55	1.20	0.00	0.00	0.00	0.00	0.00	1.20	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	86.17	21.23	1.08	0.90	0.54	0.00	1.26	0.36	0.54	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	93.72	13.39	1.67	0.00	1.67	0.00	5.02	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	109.71	16.64	0.62	0.41	0.41	0.62	2.26	0.41	0.41	0.62
Anulus Pulposus Cell, donor1	11248-116E6	235.26	18.54	3.55	3.09	0.92	1.95	0.80	0.34	1.60	1.60
Anulus Pulposus Cell, donor2	11463-119B5	157.97	12.25	1.22	1.47	1.47	0.49	0.98	0.00	2.45	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	48.52	13.03	0.45	0.45	0.45	0.45	1.80	0.90	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	60.78	17.37	0.87	1.30	0.87	1.30	2.17	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	42.80	17.12	0.00	2.14	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	75.03	12.85	1.49	0.60	0.90	0.30	0.90	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	55.64	16.44	1.26	0.00	0.00	1.26	1.26	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	41.58	5.94	0.00	0.00	0.66	0.66	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	58.15	14.94	0.65	1.30	0.00	0.32	1.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	55.34	18.93	0.49	1.46	1.46	0.49	1.94	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	32.66	8.91	0.59	0.00	1.19	0.59	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	56.12	12.43	0.38	0.75	0.00	0.38	1.13	0.38	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	42.81	16.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	36.36	11.28	1.25	2.51	0.00	2.51	2.51	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	54.69	14.33	0.66	0.33	0.66	0.00	1.81	0.49	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	70.97	17.74	0.00	0.00	0.00	0.00	1.36	1.36	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	40.41	7.69	0.45	0.45	0.60	0.30	1.21	0.15	0.30	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	42.33	10.18	2.14	0.00	1.61	0.00	0.54	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	36.28	12.09	0.57	0.76	0.76	1.13	2.27	0.38	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	33.95	10.96	0.27	0.53	0.53	0.00	2.14	0.00	0.53	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	49.75	14.63	0.98	0.00	0.98	0.98	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	43.12	10.28	0.33	0.83	1.00	0.50	0.66	0.17	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	10.81	1.20	0.00	1.20	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	24.78	0.00	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	48.89	12.52	0.34	0.69	0.17	0.00	1.20	0.17	0.17	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	16.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	62.13	18.45	0.97	1.46	0.97	0.49	2.43	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	59.19	17.08	0.76	0.76	1.14	0.00	1.52	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	35.13	8.48	1.21	0.00	1.21	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	53.01	15.39	0.57	2.28	1.14	0.00	1.71	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	47.89	11.97	0.21	0.86	0.86	0.00	1.71	0.00	0.00	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	41.55	12.39	1.03	0.52	0.77	0.26	1.81	0.00	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	62.87	20.18	0.47	0.00	0.47	0.94	0.47	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	52.41	14.79	0.64	0.64	0.32	0.32	1.29	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	29.96	6.42	0.00	0.00	0.71	0.00	0.00	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	45.63	12.28	0.00	1.75	0.58	0.58	0.58	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	46.67	12.04	0.30	0.60	0.90	0.00	2.11	0.00	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	35.64	16.63	0.00	0.00	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	56.96	17.29	0.51	0.00	1.53	1.02	1.02	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	45.84	12.73	0.51	0.25	0.00	0.51	2.29	0.25	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	31.77	10.17	0.64	0.00	0.64	1.27	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	46.61	10.79	0.43	0.00	0.00	1.29	0.43	0.00	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	43.18	9.53	1.27	1.48	1.27	0.42	1.06	0.21	0.64	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	37.12	10.44	0.00	0.00	0.00	0.00	0.87	0.58	0.29	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	52.91	14.17	0.00	0.00	0.94	0.94	0.94	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	55.10	9.83	0.34	0.34	0.85	0.17	1.19	0.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	9.27	2.32	0.00	0.00	2.32	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	65.49	8.45	0.00	10.56	0.00	0.00	6.34	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	56.60	11.58	0.00	0.86	1.72	0.86	1.07	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	34.29	9.63	0.60	0.60	0.60	0.60	2.41	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	45.93	13.85	0.00	0.73	0.00	0.73	0.73	0.00	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	47.13	10.34	0.69	1.38	0.69	0.92	1.38	0.23	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	12.75	2.55	0.00	0.00	0.00	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	41.95	12.20	0.51	0.51	1.02	1.27	2.03	0.00	0.25	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	66.06	17.34	0.21	1.24	1.65	0.62	1.45	0.00	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	47.43	7.65	0.00	0.92	0.31	0.00	2.45	0.61	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	76.96	16.73	0.48	0.48	0.96	0.48	0.96	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	67.85	13.53	1.11	0.44	0.44	0.89	1.33	0.00	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	47.30	13.73	3.05	0.00	3.05	0.00	3.05	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	83.08	13.85	0.00	1.11	2.22	0.00	1.66	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	69.11	11.39	1.06	0.79	0.53	0.00	2.12	0.79	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	51.61	9.81	1.09	1.45	0.36	1.45	1.09	0.73	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	51.83	12.53	0.12	1.35	1.47	0.25	1.84	0.00	0.12	0.49
Astrocyte - cerebellum, donor2	11580-120F5	33.03	14.04	0.17	1.54	1.20	0.17	1.54	0.00	0.00	0.68
Astrocyte - cerebellum, donor3	11661-122F5	71.31	16.99	0.42	2.73	2.10	0.21	2.94	0.42	0.00	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	16.03	2.09	0.00	1.05	0.00	0.35	0.70	0.00	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	14.72	3.72	0.00	0.97	0.49	0.49	1.62	0.00	0.16	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	12.53	3.73	0.00	0.45	0.60	0.00	0.75	0.00	0.15	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.70	11.70	0.11	0.11	0.46	0.00	0.23	0.00	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	4.01	10.77	0.00	0.00	0.25	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2.28	11.38	0.00	0.00	0.57	0.00	0.23	0.00	0.00	0.11
Basophils, donor1	12241-129G9	764.20	99.38	32.95	9.15	3.40	6.28	3.66	17.52	4.71	1.57
Basophils, donor2	12242-129H1	273.48	66.75	22.73	5.41	2.16	2.16	0.00	8.66	2.89	1.44
Basophils, donor3	12243-129H2	725.43	89.67	23.23	13.96	3.23	6.47	3.38	14.99	3.53	2.79
Bronchial Epithelial Cell, donor1	11511-119G8	193.61	27.17	3.23	1.08	0.22	1.29	0.00	0.43	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	293.06	27.43	1.37	0.91	2.29	1.37	0.91	0.46	0.46	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	251.07	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	67.79	11.30	0.63	0.63	0.00	0.00	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	119.16	13.72	0.62	0.83	0.42	0.21	1.04	0.21	0.21	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	163.05	32.70	0.92	1.15	1.38	0.69	0.46	0.46	0.69	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	122.00	16.38	1.26	1.26	0.18	0.54	0.72	0.18	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	56.68	35.97	0.52	0.93	3.61	0.31	0.52	0.72	0.10	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	15.14	10.95	0.00	0.00	0.47	0.23	0.47	0.00	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	43.49	18.55	0.64	3.20	2.88	0.32	2.24	0.64	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	31.03	0.00	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	378.15	70.44	19.72	5.64	0.00	4.51	2.82	11.27	2.82	2.25
CD14+ Monocytes, donor2	11305-117B9	389.95	54.20	20.79	13.55	3.53	2.97	3.34	14.11	5.75	0.93
CD14+ Monocytes, donor3	11381-118B4	369.26	50.05	18.88	14.49	2.41	1.76	2.41	16.25	4.39	2.41
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	403.62	43.59	4.25	1.13	1.42	6.23	1.42	2.26	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	233.89	40.94	2.65	0.38	0.76	2.65	1.14	0.76	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	348.46	41.42	4.27	0.99	0.99	4.27	2.96	0.66	1.31	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	941.01	65.34	11.42	8.82	2.46	12.29	3.76	5.78	4.77	2.60
CD14+ monocytes - mock treated, donor2	11873-125C1	1173.18	65.78	10.26	7.85	2.72	5.73	1.51	5.13	6.34	3.32
CD14+ monocytes - mock treated, donor3	11883-125D2	979.79	63.72	11.37	8.29	3.08	5.45	3.32	3.32	5.21	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1180.82	55.58	12.05	9.04	1.67	8.87	1.67	8.04	7.87	2.68
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1853.42	58.79	19.04	16.28	1.93	12.70	1.10	9.38	14.08	4.14
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2155.49	74.38	23.80	23.31	2.48	14.38	3.47	7.19	13.39	3.72
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1529.40	56.00	14.29	9.59	2.94	12.34	4.50	7.64	8.22	1.96
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1398.04	47.72	15.67	8.72	3.56	10.86	2.31	5.88	7.48	1.96
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1743.00	80.96	18.93	9.36	3.48	18.50	2.39	8.49	13.71	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	790.18	33.95	9.13	3.75	1.17	4.45	3.28	5.85	4.45	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1767.31	60.72	16.90	15.31	5.28	6.34	1.58	14.78	10.03	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1486.54	88.75	11.09	19.97	3.33	5.55	1.11	13.31	8.87	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1555.02	87.32	15.77	17.85	3.42	20.38	3.12	6.99	11.16	5.06
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1704.94	89.20	15.37	16.96	2.59	10.38	1.00	5.79	13.37	2.79
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1599.39	76.41	15.61	9.79	1.25	16.03	1.25	5.62	12.91	2.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1108.69	47.36	8.24	4.58	1.83	11.67	2.75	5.72	6.18	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1612.83	62.43	20.36	8.14	1.58	11.54	1.13	4.75	13.57	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1107.30	45.39	9.17	3.93	1.75	5.67	0.87	6.98	5.67	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1050.94	44.92	11.57	6.72	3.50	10.49	3.50	5.92	4.03	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1246.87	55.30	14.65	10.29	2.27	12.56	2.97	7.85	8.90	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1203.55	47.13	14.73	7.57	2.52	5.05	4.63	11.36	3.37	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1354.32	52.17	12.68	3.12	4.23	10.47	2.20	8.82	10.84	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1472.12	49.32	8.10	4.58	2.82	9.86	1.76	7.75	7.75	2.82
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1458.76	49.58	12.28	4.39	5.70	6.58	1.75	5.26	7.46	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1613.83	63.65	16.04	10.11	2.96	13.43	3.31	5.93	9.24	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1995.53	69.13	18.21	13.75	4.83	14.50	2.23	7.81	10.78	5.20
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2160.24	85.36	26.51	15.95	1.94	19.61	2.16	9.27	12.50	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	864.02	40.95	8.19	4.09	1.64	7.78	2.05	3.28	4.50	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1488.38	53.55	16.92	1.16	1.85	8.11	2.09	5.79	11.59	1.62
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	957.89	43.85	9.28	2.78	2.32	11.37	1.86	6.26	7.42	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	741.30	138.63	38.80	4.14	2.18	11.55	1.31	16.13	9.37	6.76
CD14+CD16+ Monocytes, donor2	11801-124D1	722.09	127.05	30.49	6.24	2.08	12.24	0.00	15.48	10.63	7.39
CD14+CD16+ Monocytes, donor3	11912-125G4	678.66	112.64	30.76	4.98	2.82	6.72	1.30	12.78	7.36	6.93
CD14+CD16- Monocytes, donor1	11788-124B6	1007.37	179.39	36.59	8.72	3.27	14.64	2.34	26.94	7.47	6.23
CD14+CD16- Monocytes, donor2	11799-124C8	841.61	130.11	25.67	8.38	3.49	10.83	2.62	18.51	6.29	2.97
CD14+CD16- Monocytes, donor3	11910-125G2	608.48	98.55	20.74	5.35	2.45	4.68	2.01	16.50	6.47	2.68
CD14-CD16+ Monocytes, donor1	11790-124B8	803.29	130.39	31.13	4.34	2.04	9.95	0.77	14.29	5.87	5.36
CD14-CD16+ Monocytes, donor2	11800-124C9	791.09	113.73	29.64	4.61	1.10	12.95	0.66	11.64	6.59	5.27
CD14-CD16+ Monocytes, donor3	11911-125G3	871.24	113.69	35.16	4.84	2.95	7.16	0.42	14.11	8.84	6.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	36.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	21.02	42.03	0.68	0.68	0.68	1.36	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	7.25	44.53	0.00	0.00	0.00	0.00	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	32.52	51.70	0.53	1.07	0.00	0.53	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	11.26	48.25	0.00	0.00	0.54	0.00	0.00	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	16.14	42.12	0.00	0.70	2.11	0.00	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.02	61.96	0.00	0.00	0.00	0.00	0.78	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	15.82	39.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	18.08	22.19	0.82	1.64	1.64	0.00	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	25.39	23.21	0.73	0.00	0.00	0.00	0.00	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	14.64	16.15	0.00	1.01	2.02	0.00	2.02	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	89.70	30.30	0.00	0.00	1.21	0.00	0.81	0.00	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	94.68	23.97	0.00	0.00	0.40	0.40	0.00	0.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	30.12	8.03	0.00	2.01	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	111.24	25.28	3.37	5.06	3.93	0.56	2.25	1.69	2.25	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	23.30	18.79	0.00	0.00	2.25	0.38	1.13	0.38	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.00	25.93	0.45	0.23	1.13	0.23	0.45	0.68	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	62.13	20.35	0.71	1.43	7.14	0.36	2.50	1.43	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	63.69	27.56	0.00	1.84	7.35	0.61	2.45	1.22	1.22	1.22
CD4+ T Cells, donor3	11382-118B5	68.32	31.41	0.61	2.44	6.40	0.30	1.83	1.52	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	3.06	40.33	0.00	0.00	0.77	0.00	0.26	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	4.04	43.57	0.00	0.00	0.45	0.00	0.00	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	3.16	45.99	0.00	0.00	1.44	0.00	0.29	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	34.61	64.00	0.00	1.90	8.06	0.47	1.90	0.95	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	37.22	79.36	0.00	0.00	6.32	0.00	1.40	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	56.04	0.00	0.00	13.18	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	7.66	39.02	0.00	0.00	1.30	0.14	0.72	0.14	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	5.59	30.33	0.34	0.00	2.03	0.00	0.17	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	5.64	32.72	0.16	0.00	1.61	0.00	0.16	0.16	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	18.83	36.76	0.45	0.45	2.69	0.00	0.90	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	16.07	47.52	0.00	0.00	5.94	0.00	0.35	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	14.96	35.20	0.44	0.00	1.32	0.44	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	5.90	40.06	0.00	0.00	0.42	0.00	0.42	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	5.61	33.87	0.21	0.00	1.25	0.00	0.42	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	4.01	38.42	0.00	0.00	1.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	66.90	69.34	0.00	1.09	8.16	1.09	2.72	1.36	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	58.42	57.35	0.00	0.54	4.82	0.00	2.68	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	50.21	50.21	1.79	0.00	8.97	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	6.30	40.61	0.00	0.37	1.11	0.00	0.19	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	4.98	38.56	0.00	0.00	0.22	0.00	0.22	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	6.09	43.92	0.21	0.00	0.63	0.21	0.63	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	55.62	59.16	0.51	0.51	6.07	1.01	1.52	0.51	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	72.79	57.62	0.43	2.60	5.63	1.30	0.87	0.87	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	68.86	46.20	0.44	0.00	2.61	0.00	1.31	0.87	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	21.77	84.13	0.49	0.49	3.46	0.00	2.47	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	8.31	70.16	0.00	0.00	1.85	0.00	2.77	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	4.19	73.98	0.00	0.00	0.00	0.00	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	49.85	57.88	0.55	0.00	2.49	0.28	1.38	0.00	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	23.31	64.05	0.25	0.25	2.45	0.49	1.23	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	49.28	63.14	3.08	0.00	0.00	3.08	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	86.31	72.34	1.43	0.00	2.51	1.07	0.72	0.00	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	23.54	95.56	0.00	0.00	2.77	0.00	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	68.43	51.40	0.33	1.31	2.62	0.00	0.98	2.62	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	61.95	55.94	0.75	3.00	4.13	1.50	3.38	1.50	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	62.11	44.69	1.01	3.28	6.31	0.00	3.28	1.26	0.25	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	49.55	9.86	0.92	0.00	2.52	0.46	0.23	0.23	0.00	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	52.96	9.59	0.48	0.00	1.92	0.24	0.00	0.72	0.72	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	45.14	8.75	0.55	0.27	0.82	1.09	0.55	0.55	0.27	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	43.23	11.41	0.00	0.30	1.20	0.00	0.30	0.30	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	62.16	9.36	0.00	0.48	2.16	0.48	0.00	0.24	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	47.98	10.23	0.68	0.23	1.59	0.23	0.23	0.45	0.23	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	48.02	6.08	0.65	0.00	1.30	0.43	0.22	1.09	0.22	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	46.59	6.32	0.26	0.26	1.58	0.00	0.53	1.05	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	53.47	7.27	1.41	0.23	1.17	0.00	0.70	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	76.68	9.36	0.00	1.21	1.81	0.30	0.30	1.51	0.60	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	69.43	12.20	0.58	0.29	2.03	0.87	0.58	0.87	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	80.20	10.92	0.80	0.53	1.87	0.27	0.27	0.80	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	192.61	14.45	3.94	2.63	2.19	0.88	0.00	2.63	3.06	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	235.91	18.22	4.55	1.82	3.64	1.37	0.46	0.46	1.82	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	181.99	7.46	2.24	2.98	2.24	1.49	0.00	0.00	1.49	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	58.35	10.08	0.36	0.36	0.72	0.00	0.72	0.72	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	56.68	8.06	0.58	0.00	1.15	0.86	0.86	0.29	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	43.60	9.19	1.18	0.24	3.06	0.00	0.71	1.41	0.24	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	72.57	11.09	1.27	0.63	2.22	0.32	0.32	0.32	0.32	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	60.28	8.61	1.54	0.31	0.31	0.92	0.92	0.92	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	53.86	8.01	0.96	0.32	1.60	0.32	0.32	0.96	0.64	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	99.82	11.09	1.53	1.15	0.76	1.15	0.38	1.15	0.00	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	110.35	11.82	1.18	0.39	3.15	0.79	0.79	1.18	0.79	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	109.68	9.08	0.76	0.76	2.27	0.00	0.76	0.00	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	331.62	39.34	3.21	2.41	8.03	0.80	0.80	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	283.97	29.38	3.50	2.80	4.90	2.80	1.40	2.80	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	420.74	38.07	4.01	0.00	4.01	0.00	1.00	1.00	3.01	0.00
Cardiac Myocyte, donor1	11525-119I4	118.80	14.62	1.83	0.00	5.48	0.00	0.00	1.83	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	166.01	16.80	0.99	4.45	0.00	0.99	1.48	1.48	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	109.02	17.26	0.74	1.26	0.74	0.42	0.74	0.42	0.32	0.53
Chondrocyte - de diff, donor1	11261-116G1	120.29	14.56	1.04	0.69	0.00	0.69	1.39	0.00	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	204.34	27.36	2.49	0.00	2.84	0.36	1.07	0.36	1.07	1.42
Chondrocyte - de diff, donor3	11410-118E6	197.52	19.80	1.93	1.82	3.41	1.37	1.02	0.57	0.91	1.37
Chondrocyte - re diff, donor2	11339-117F7	135.18	22.38	0.90	1.79	0.90	0.90	0.90	0.00	0.90	1.79
Chondrocyte - re diff, donor3	11411-118E7	171.47	12.54	0.40	3.24	3.64	1.21	2.43	0.81	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	63.00	7.00	0.34	1.03	0.23	0.23	1.26	0.11	0.11	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	47.67	7.48	0.64	1.28	1.71	0.86	0.64	0.64	0.00	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	48.59	7.88	0.71	1.42	0.62	0.35	1.50	0.35	0.53	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	141.68	12.93	1.47	2.38	1.19	2.38	0.92	0.83	0.83	0.37
Corneal Epithelial Cells, donor1	11526-119I5	243.29	41.28	1.98	0.88	1.32	1.32	1.10	0.44	1.32	1.10
Corneal Epithelial Cells, donor2	11606-120I4	122.86	10.24	3.41	0.00	1.14	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	142.64	21.47	1.79	0.77	0.51	0.51	0.51	0.51	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	124.81	15.52	2.15	0.83	1.82	0.99	0.17	0.17	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	146.67	16.72	2.84	1.26	2.84	1.58	0.00	0.32	0.95	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	13.80	0.00	0.00	0.00	3.45	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	178.51	14.25	3.02	0.65	2.05	1.19	0.32	1.08	0.97	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	52.27	4.44	1.37	0.00	0.34	0.34	0.68	0.68	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	40.48	3.26	1.96	0.65	0.00	1.31	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.49	1.45	1.45	0.48	0.48	0.00	0.00	0.97	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	13.84	20.51	0.17	0.00	0.33	0.00	0.67	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	25.82	17.60	0.00	0.00	0.00	0.00	1.76	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	5.37	16.40	0.00	0.28	0.28	0.00	0.57	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	4.33	6.29	0.00	0.00	1.18	0.00	0.79	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	10.76	14.54	0.00	0.29	0.29	0.29	0.87	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	6.12	12.23	0.00	0.00	0.47	0.24	0.47	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	5.79	10.52	0.18	0.00	0.70	0.00	0.18	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.97	7.31	0.00	0.00	0.22	0.22	0.89	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	11.26	10.95	0.00	0.00	1.22	0.30	0.91	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	11.28	9.58	0.28	0.00	0.28	0.28	0.28	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	19.31	13.07	0.00	0.00	1.49	0.00	0.89	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	21.87	13.54	0.52	0.52	0.52	0.00	1.04	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	24.53	15.45	0.00	0.57	2.13	0.00	1.84	0.14	0.14	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	6.00	15.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	4.72	12.58	0.00	0.00	1.05	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	7.08	11.31	0.00	0.12	0.99	0.00	1.12	0.00	0.00	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	3.69	6.95	0.00	0.22	0.65	0.00	0.43	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	6.47	14.29	0.12	0.12	0.24	0.00	0.24	0.00	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	5.69	5.69	0.00	0.00	3.41	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.29	9.08	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	6.28	12.40	0.00	0.16	1.88	0.00	0.63	0.00	0.00	0.16
Eosinophils, donor1	12244-129H3	198.21	121.98	0.00	0.00	0.00	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	5581.19	630.40	51.16	117.17	13.20	31.35	19.80	49.51	11.55	6.60
Eosinophils, donor3	12246-129H5	5150.49	463.69	82.04	121.27	7.13	39.24	35.67	39.24	17.83	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	175.67	18.32	2.20	0.24	1.22	0.98	0.98	0.49	0.73	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	235.06	37.44	2.08	2.08	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	195.23	16.27	0.00	0.00	0.00	0.00	0.00	32.54	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	57.88	20.12	0.82	0.82	5.34	0.41	0.82	0.00	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	87.92	21.24	1.64	0.44	2.19	1.20	0.77	0.55	1.75	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	108.99	26.00	0.76	2.28	2.17	3.25	1.19	0.43	0.54	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	75.56	22.56	0.73	0.24	1.58	0.73	0.85	0.24	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	88.71	27.43	0.68	0.41	3.14	0.41	0.14	0.82	1.23	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	167.27	25.42	2.00	1.58	1.69	2.21	0.74	0.74	2.11	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	101.44	19.76	1.05	0.26	1.84	0.00	0.79	0.00	1.32	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	86.70	16.28	1.33	1.33	1.33	0.33	1.00	0.00	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	64.87	18.15	0.45	0.00	3.18	0.45	0.00	0.00	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	64.43	12.13	1.52	1.52	0.76	0.00	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	52.20	22.40	0.63	0.95	2.68	0.32	1.58	0.63	0.32	0.63
Fibroblast - Cardiac, donor4	11452-119A3	66.68	14.85	0.61	0.61	1.21	0.30	0.61	0.30	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	89.09	27.67	0.89	1.40	1.90	0.51	1.27	0.13	0.51	0.89
Fibroblast - Cardiac, donor6	11460-119B2	50.48	12.43	0.15	0.91	0.45	0.30	1.67	0.00	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	143.24	17.28	1.88	1.34	0.54	0.27	1.74	0.13	0.40	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	98.37	17.26	0.86	1.29	1.73	0.00	0.43	1.29	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	118.65	24.90	2.93	5.86	0.00	1.46	0.00	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	357.72	102.17	1.85	5.07	3.46	2.54	1.61	2.54	2.77	5.07
Fibroblast - Conjunctival, donor3	11692-122I9	101.76	23.24	1.02	3.22	2.20	0.68	1.36	0.17	1.02	0.34
Fibroblast - Dermal, donor1	11269-116G9	222.57	39.44	3.99	1.64	2.35	1.64	0.70	0.70	2.58	1.88
Fibroblast - Dermal, donor2	11346-117G5	190.56	19.34	2.36	0.47	0.47	0.00	0.47	0.00	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	231.50	34.21	3.63	2.18	3.02	1.45	1.21	0.48	2.42	2.90
Fibroblast - Dermal, donor4	11450-119A1	76.87	27.92	0.79	1.13	1.58	0.23	0.57	0.34	0.23	2.37
Fibroblast - Dermal, donor5	11454-119A5	73.27	15.00	0.35	0.70	0.87	0.00	1.22	0.87	0.70	1.40
Fibroblast - Dermal, donor6	11458-119A9	56.69	11.53	0.00	0.16	0.81	0.32	0.65	0.49	0.00	0.65
Fibroblast - Gingival, donor1	11237-116D4	159.92	17.07	0.42	1.04	0.83	2.08	1.04	0.42	0.83	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	108.99	24.63	1.31	1.83	2.62	0.52	1.05	0.26	0.79	1.05
Fibroblast - Gingival, donor2	11318-117D4	48.36	14.23	0.26	1.19	0.79	0.13	1.19	0.40	0.53	0.26
Fibroblast - Gingival, donor3	11394-118C8	289.96	28.04	1.55	2.42	1.55	0.68	1.06	1.55	1.16	3.38
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	318.94	40.52	1.04	5.19	2.08	7.27	1.04	1.04	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	236.47	28.54	2.64	1.59	1.94	5.29	1.41	0.53	1.76	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	123.16	20.58	0.78	1.25	1.40	0.62	0.94	1.25	0.31	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	73.70	15.28	0.68	0.68	0.81	0.68	1.62	0.27	0.54	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	200.08	30.35	3.53	1.41	0.71	0.71	0.71	0.71	0.35	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	69.76	15.79	1.32	0.58	0.73	0.58	1.32	0.15	0.44	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	117.67	13.36	0.82	0.68	0.95	0.41	0.82	0.68	0.82	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	86.55	18.43	0.99	0.66	0.77	0.33	1.21	0.44	0.11	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	154.08	25.09	1.76	1.76	1.61	2.05	1.32	0.44	0.44	1.17
Fibroblast - Lung, donor1	11270-116H1	130.50	19.03	2.72	0.00	1.36	1.36	1.36	1.36	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	158.17	22.38	1.49	2.98	1.49	0.00	1.49	1.49	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	194.36	21.53	1.69	3.80	1.06	1.06	1.90	1.90	0.42	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	210.75	42.48	1.67	0.00	1.67	0.83	0.83	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	86.71	18.18	1.40	0.00	5.59	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	198.71	47.30	1.68	0.84	3.36	0.84	1.12	0.84	0.84	1.96
Fibroblast - Mammary, donor1	11540-120B1	264.69	36.54	3.65	1.22	1.62	0.41	0.41	1.62	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	143.79	43.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	29.78	0.00	0.00	0.00	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	67.50	14.16	0.00	0.78	0.39	0.39	1.75	0.19	0.19	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	67.65	15.93	0.30	1.21	0.61	0.30	0.61	0.30	0.76	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	120.87	18.05	1.22	1.22	0.31	0.31	0.31	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	65.64	15.26	0.00	1.14	1.91	0.38	1.53	0.38	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	147.68	21.87	2.43	1.62	2.97	2.16	1.08	0.27	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	250.27	19.25	3.02	2.09	1.51	3.02	1.04	0.81	2.67	1.51
Fibroblast - Pulmonary Artery, donor1	11250-116E8	54.16	15.14	1.22	0.88	0.88	0.44	0.77	0.33	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	133.90	28.04	1.63	0.81	0.81	0.00	1.22	0.20	0.41	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	115.60	16.04	1.34	2.00	2.00	0.67	2.00	2.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	124.14	20.56	0.79	1.19	0.00	0.40	1.19	0.79	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	71.24	12.70	0.40	0.20	0.60	0.20	0.40	0.00	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	139.61	18.65	1.07	0.89	1.60	0.71	1.24	0.36	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	143.28	13.60	1.97	0.59	1.97	0.79	0.79	0.00	0.20	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	65.89	15.04	1.20	0.30	0.60	0.00	0.00	0.90	0.30	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	107.52	12.85	0.76	0.97	1.30	1.19	1.08	0.32	0.43	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	136.41	18.98	0.00	0.51	0.76	0.00	0.76	0.76	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	118.30	21.00	1.31	0.98	1.48	0.98	0.98	0.66	0.16	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	59.95	19.85	1.20	0.00	2.21	1.20	0.20	0.60	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	107.80	24.21	0.30	0.40	2.21	1.00	1.61	0.20	0.40	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	157.77	16.02	0.00	0.00	1.21	0.60	0.00	0.60	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	136.94	15.82	1.33	0.66	1.49	1.16	0.75	0.58	0.75	0.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	132.66	15.39	0.34	1.20	1.71	1.71	0.68	0.00	0.34	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	93.60	15.11	0.99	0.33	0.99	0.66	0.33	0.33	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	67.64	15.34	0.64	0.32	1.28	0.32	0.43	0.21	0.32	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	84.68	17.21	0.34	0.34	0.67	0.67	1.35	0.17	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	80.13	17.41	1.10	0.47	0.31	0.94	0.47	0.78	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	162.10	12.20	1.74	2.61	1.74	0.87	1.74	1.74	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	89.63	22.19	1.04	0.69	0.69	1.91	0.35	0.52	0.52	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	83.02	21.86	0.52	0.26	0.26	0.26	0.78	0.00	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	69.50	14.05	1.28	0.51	1.02	0.00	0.26	0.77	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	9.19	9.95	0.00	0.77	0.00	0.00	0.77	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.85	9.57	0.00	0.00	0.00	0.00	0.64	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	33.38	10.27	0.00	3.42	0.57	0.57	4.28	0.86	0.29	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	5.52	1.65	0.28	1.10	0.28	0.28	1.38	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	46.12	8.68	0.23	1.14	0.68	1.83	1.14	0.23	0.00	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	23.58	7.13	0.20	1.59	0.79	0.79	3.57	0.00	0.59	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	6.08	3.44	0.00	1.59	0.26	0.79	2.38	0.26	0.00	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	50.55	7.50	0.00	2.94	1.63	3.59	3.59	0.33	0.00	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	18.13	6.19	0.00	2.21	1.77	0.88	3.10	0.44	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	23.32	6.78	0.00	4.38	0.57	0.85	2.26	0.42	0.28	2.26
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	37.68	6.40	0.86	2.83	0.86	0.49	4.06	0.37	0.12	2.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.73	11.01	0.00	1.61	3.76	0.54	2.42	0.27	1.88	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	52.41	8.18	1.24	3.47	0.12	0.37	3.35	0.25	0.50	2.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	56.34	8.17	0.97	3.60	0.42	0.42	3.88	1.25	0.14	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	39.03	10.98	0.61	2.64	0.00	0.41	2.44	0.81	0.20	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	41.30	14.60	1.37	1.14	0.23	0.23	2.97	0.23	0.23	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	52.94	12.95	1.00	2.12	0.12	0.62	3.36	1.00	0.12	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	54.64	17.92	1.31	4.81	0.66	0.44	1.75	0.87	0.00	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.73	15.36	1.18	2.07	0.59	0.30	1.48	0.89	0.30	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	35.13	9.54	0.48	1.11	0.32	0.48	2.54	0.79	0.16	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	38.20	16.53	0.67	2.46	0.67	0.00	2.01	1.34	0.22	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	27.62	10.48	1.01	1.21	0.20	0.60	3.02	0.60	0.00	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	44.45	10.18	0.85	1.19	0.17	0.34	2.54	0.17	0.00	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	48.68	15.07	1.06	1.15	0.71	0.80	1.24	0.89	0.44	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.33	8.22	0.31	1.77	0.10	0.00	2.08	0.21	0.10	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.20	9.22	0.17	1.54	0.34	0.51	1.20	0.34	0.51	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	28.77	8.41	0.55	1.33	0.55	0.22	2.88	0.33	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.10	11.73	0.58	0.83	0.50	0.58	1.91	0.42	0.33	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.43	13.88	1.43	0.61	0.61	0.61	1.43	0.61	0.00	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.04	8.87	0.41	1.65	0.62	0.62	2.89	0.21	0.21	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	26.75	7.61	0.23	1.96	0.35	0.23	3.23	0.58	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	49.03	13.34	0.67	1.50	1.00	0.67	2.17	1.17	0.50	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	21.82	10.14	0.00	1.76	0.00	0.88	3.75	0.44	0.22	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	38.37	9.96	0.74	2.34	0.49	0.12	2.21	0.37	0.12	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	42.47	8.27	0.49	2.11	0.65	0.49	2.27	0.65	0.16	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.60	8.66	0.64	3.53	0.00	0.32	2.89	1.28	0.32	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.28	9.38	0.76	1.42	0.38	0.28	4.26	0.66	0.09	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	44.29	10.28	0.63	2.06	0.32	0.16	1.90	0.47	0.16	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.06	10.03	0.00	0.91	0.30	0.00	2.43	0.00	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	35.23	7.11	0.21	1.25	0.42	0.21	2.61	0.42	0.00	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.93	11.86	0.88	1.98	1.10	0.44	3.73	0.66	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	20.20	8.70	1.68	0.84	0.00	0.00	1.68	0.56	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.02	9.72	0.46	0.46	0.28	0.19	1.94	0.46	0.19	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.32	10.16	0.80	0.80	0.53	0.80	1.60	0.27	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	60.59	18.82	1.38	1.07	0.31	0.61	1.07	0.46	1.22	1.84
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	57.77	11.53	0.26	1.17	1.04	0.26	2.59	0.26	0.13	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	28.73	9.22	0.27	0.81	0.54	0.00	2.44	0.27	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.57	10.88	0.37	0.18	0.74	0.18	2.40	0.37	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	30.05	11.62	0.88	1.75	0.44	0.22	2.41	0.44	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	27.77	8.93	0.00	1.98	0.99	0.00	1.98	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	35.48	15.04	0.53	0.26	0.26	0.13	2.37	0.26	0.26	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	52.46	15.74	0.40	0.81	1.01	0.00	1.61	0.40	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	23.64	10.67	0.00	0.51	0.51	0.00	0.51	0.00	0.51	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	17.92	7.17	0.00	3.58	1.00	0.40	2.19	0.00	0.20	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	33.90	10.17	0.00	6.16	0.77	0.46	2.77	0.31	0.15	3.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	18.41	7.57	0.20	5.11	0.41	0.20	3.68	0.20	0.41	3.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	12.20	8.76	0.31	0.94	0.00	0.31	3.76	0.00	0.31	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	10.74	4.24	0.00	0.57	1.13	0.00	1.98	0.28	0.00	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	15.68	4.61	0.46	2.77	1.38	0.00	3.23	0.00	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	9.90	0.00	0.00	0.00	0.00	0.00	0.00	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	20.11	8.90	0.77	3.87	0.00	0.39	1.55	0.00	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	9.63	0.00	0.00	1.60	3.21	0.00	0.00	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	3.48	0.00	5.22	1.74	0.00	3.48	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	21.48	3.91	0.00	0.98	0.65	0.65	2.28	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	22.65	7.41	0.41	1.24	0.00	1.24	3.71	0.00	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	6.66	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	15.38	5.03	0.28	0.84	0.00	0.28	3.08	0.00	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	23.21	7.84	0.00	3.92	0.00	0.65	1.63	0.33	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	11.74	5.87	1.68	0.84	0.84	0.00	3.36	0.00	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	15.27	8.27	0.64	0.95	0.32	0.64	2.86	0.00	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.95	4.08	0.00	1.36	1.02	0.00	0.34	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	4.18	0.00	4.18	0.00	0.00	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	17.18	4.01	0.00	1.15	0.00	0.00	3.44	0.00	0.00	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.02	3.26	0.30	1.18	0.00	0.00	1.48	0.00	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	5.08	0.00	0.00	0.00	0.00	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	15.33	5.38	0.00	0.83	0.00	0.00	2.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	7.59	2.30	0.00	0.69	0.00	0.00	1.38	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	0.00	0.00	0.00	5.27	5.27	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	9.61	2.31	0.00	2.31	0.77	0.00	1.54	0.00	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.39	3.91	0.00	1.30	0.33	0.00	2.61	0.33	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	22.07	2.68	0.00	4.01	0.00	0.00	4.68	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	21.58	3.47	0.00	2.31	0.00	0.39	3.08	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	23.62	7.53	0.00	0.68	0.34	0.00	2.40	0.00	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	7.45	0.00	0.00	0.00	0.00	7.45	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	19.82	3.30	0.00	1.89	0.00	0.47	3.30	0.47	0.00	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	27.16	7.85	0.00	1.81	0.60	0.00	4.83	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	25.94	5.09	1.02	2.54	0.51	0.00	2.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	25.92	3.59	0.00	1.99	0.00	0.00	3.59	0.40	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	31.08	3.45	0.00	3.45	0.00	0.00	1.97	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	36.59	2.36	0.00	1.18	0.00	0.00	1.18	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	28.01	2.33	0.58	1.75	0.58	0.58	4.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	53.10	8.78	0.88	3.51	0.00	0.00	2.63	0.44	0.88	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	44.93	7.63	0.00	6.78	0.85	0.00	1.70	0.85	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	17.31	3.58	0.00	2.39	0.00	0.60	1.19	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	17.95	5.34	0.00	1.46	0.49	0.49	0.49	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	184.89	22.83	4.57	1.14	0.00	0.00	0.00	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	121.83	19.54	1.25	1.25	0.00	1.66	2.49	1.25	0.00	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	98.95	16.87	0.00	0.00	1.12	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	214.08	24.42	1.59	0.95	2.85	1.59	0.95	0.32	1.27	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	96.50	20.89	2.51	0.42	2.09	0.00	0.00	0.00	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	73.11	12.30	0.58	0.12	0.35	0.81	1.04	0.93	0.23	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	89.30	11.82	0.34	1.18	0.84	0.00	0.84	0.00	0.17	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	65.52	5.92	0.23	0.23	0.00	0.46	1.14	0.00	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	84.28	12.02	0.55	0.55	0.77	0.33	0.98	0.22	0.44	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	107.67	10.32	1.29	0.64	0.86	0.21	0.43	0.43	0.43	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	68.24	4.52	0.65	0.00	0.22	0.00	0.43	0.43	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	40.97	6.97	0.50	0.37	0.75	0.50	0.62	0.12	0.50	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	44.60	6.35	0.34	0.51	0.69	0.00	0.69	0.34	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	39.09	4.81	0.32	0.32	0.96	0.32	0.00	0.32	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	12.87	0.56	0.00	0.56	0.00	1.12	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	95.65	18.61	1.73	0.00	0.43	0.43	1.30	0.43	0.87	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	15.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	188.35	16.23	1.06	2.12	0.71	0.35	2.12	0.71	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	151.84	9.44	2.18	2.18	1.45	0.00	1.45	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	106.65	21.33	0.87	1.05	0.70	0.87	0.87	0.00	0.35	0.35
Hepatocyte, donor1	11523-119I2	336.55	1.21	2.42	1.21	1.21	2.42	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	400.77	14.01	6.46	1.08	0.00	1.08	0.00	1.08	3.23	1.08
Hepatocyte, donor3	11684-122I1	357.69	11.66	4.91	8.59	1.23	0.61	0.00	1.84	2.45	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	49.60	47.65	0.00	0.00	3.26	0.65	0.00	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	149.96	24.12	2.80	4.37	0.52	0.87	2.97	1.40	0.17	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	59.68	9.19	0.82	1.10	0.27	0.14	0.96	0.41	0.41	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	38.21	0.00	3.18	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	60.08	13.35	0.00	6.68	0.00	13.35	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	62.30	29.07	0.00	1.38	1.38	0.00	4.15	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	165.18	65.07	2.50	0.00	5.01	0.00	2.50	2.50	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	11.87	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	79.45	56.38	0.00	0.00	5.13	0.00	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	164.55	109.70	0.00	4.57	0.00	0.00	0.00	0.00	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	90.96	40.61	1.62	1.62	1.62	0.00	0.00	3.25	0.00	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	63.36	30.01	0.00	1.67	0.00	0.00	3.33	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	159.74	61.72	0.00	0.00	3.63	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	99.26	78.08	0.00	0.00	2.65	5.29	3.97	2.65	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	49.89	39.91	0.00	0.00	1.11	0.00	1.11	2.22	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	125.72	62.86	5.24	0.00	0.00	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	74.32	38.42	0.63	1.26	2.52	0.63	1.89	0.63	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	49.49	24.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	60.08	37.47	1.29	0.00	1.94	1.29	1.29	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	66.01	37.03	0.00	1.61	0.00	0.00	1.61	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	47.79	0.00	11.95	0.00	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	48.89	29.34	0.00	0.81	3.26	0.00	2.44	0.81	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	42.82	34.00	0.84	0.42	2.94	0.00	2.94	0.00	0.42	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	28.74	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	51.44	26.52	0.80	0.00	1.61	0.00	3.21	0.80	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	33.24	28.62	0.00	0.00	0.92	0.00	2.77	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	31.15	21.71	0.00	0.00	0.47	0.47	2.36	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	26.30	23.58	0.00	0.91	0.91	0.91	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	32.28	20.45	0.00	0.00	0.00	0.00	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	27.95	20.33	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	25.51	21.04	0.00	0.00	0.64	0.00	0.64	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	23.69	0.00	0.00	0.00	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	24.99	16.42	0.00	0.71	0.71	0.00	3.57	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	26.55	0.00	0.00	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	24.08	17.59	0.00	0.31	1.23	0.00	1.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	45.66	26.34	0.00	1.76	0.00	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	18.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	36.86	14.60	0.00	0.70	0.70	0.00	1.39	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	112.87	84.10	0.00	2.21	4.43	2.21	4.43	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	113.47	103.74	0.00	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	145.61	58.42	1.74	0.87	3.49	0.00	2.62	4.36	0.87	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	164.23	71.99	4.50	0.00	4.50	0.00	0.00	0.00	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	118.48	66.21	3.48	0.00	3.48	0.00	6.97	6.97	0.00	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	196.29	45.87	5.33	1.07	4.27	0.00	4.27	1.07	0.00	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	94.21	55.42	4.16	2.77	2.77	0.00	0.00	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	39.89	0.00	0.00	0.00	0.00	2.85	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	105.85	46.94	0.00	4.60	5.52	1.84	2.76	0.92	0.00	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	160.34	60.51	0.00	6.05	0.00	6.05	0.00	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	223.51	62.09	6.21	6.21	6.21	0.00	0.00	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	197.73	33.84	3.17	0.00	3.17	0.00	2.11	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	102.90	14.77	1.88	0.73	0.57	1.14	0.49	0.16	0.57	0.08
Keratinocyte - epidermal, donor2	11349-117G8	187.40	42.17	0.00	1.17	1.76	0.59	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	104.12	20.92	0.95	0.85	0.85	0.19	0.76	0.28	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	132.47	22.59	1.36	0.45	1.25	0.91	0.34	0.91	0.00	0.23
Keratocytes, donor1	11527-119I6	354.83	82.18	3.09	4.47	0.34	1.38	3.44	2.41	1.38	6.88
Keratocytes, donor2	11607-120I5	82.03	18.75	0.00	0.00	0.00	0.00	1.17	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	174.08	41.69	1.58	3.95	1.19	0.00	0.99	2.17	1.19	3.36
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	15.39	0.00	2.20	4.40	2.20	4.40	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	46.39	12.94	1.08	0.00	1.08	0.00	0.00	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	63.43	6.34	0.35	1.38	0.23	0.23	1.73	0.23	0.23	0.69
Lens Epithelial Cells, donor3	11690-122I7	62.46	22.10	1.01	0.61	1.21	0.81	0.61	0.30	0.40	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	95.93	14.23	0.95	0.71	0.83	0.59	1.90	0.24	0.24	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	102.42	16.19	0.56	0.56	0.84	0.28	1.40	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	59.03	15.11	0.16	0.16	0.94	0.31	1.73	0.16	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	89.26	15.06	1.61	0.54	0.54	0.54	2.69	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	90.14	17.96	0.63	0.95	0.63	0.63	1.58	0.32	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	61.78	13.80	1.19	0.65	1.08	0.32	1.62	0.43	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	103.83	12.72	2.05	0.82	0.82	0.41	0.41	0.00	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	127.93	17.44	1.77	2.02	0.51	0.51	0.76	0.51	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	72.49	13.93	0.70	0.70	0.84	0.42	1.97	0.28	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	84.64	12.66	0.40	0.79	0.00	0.00	1.19	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	116.72	18.61	0.39	1.36	0.19	0.39	3.49	0.58	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	89.06	13.52	1.11	0.93	0.93	0.37	1.11	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	111.15	12.19	1.74	2.44	1.05	0.35	1.39	0.35	0.00	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	114.01	12.88	0.72	0.24	0.72	0.00	3.10	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	69.91	14.15	0.82	0.96	0.69	0.14	0.82	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	88.08	13.86	3.39	0.92	1.23	0.00	0.92	0.31	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	104.75	10.60	1.56	1.56	0.31	0.31	1.56	0.94	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	81.61	17.02	0.37	0.37	0.18	0.00	0.55	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	116.51	10.20	2.63	1.65	0.33	0.33	1.65	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	113.05	13.76	0.59	1.76	0.88	0.59	2.34	0.88	0.00	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	63.23	16.43	0.50	1.00	0.00	0.00	3.24	0.75	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	87.29	12.12	1.45	1.45	0.97	0.48	0.97	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	66.79	12.66	0.54	0.54	1.08	0.27	0.81	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.37	11.96	0.76	0.61	0.91	0.00	0.76	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	93.31	10.89	0.52	1.04	2.07	0.00	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	87.94	9.84	0.63	1.05	0.42	0.42	1.88	0.63	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	35.34	12.63	0.30	0.15	1.20	0.15	1.80	0.60	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	61.91	11.69	0.00	0.69	0.00	0.00	0.69	0.00	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	85.80	12.23	0.75	0.56	0.38	0.19	2.07	0.19	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	43.15	12.30	0.32	0.53	0.53	0.21	1.38	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	76.56	11.63	0.97	0.48	0.48	0.00	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	79.39	10.92	1.32	0.33	0.33	0.33	2.32	0.00	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	55.50	12.14	0.25	0.74	0.62	0.00	1.73	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	86.26	12.59	0.74	1.11	0.37	0.37	0.37	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	72.40	8.65	0.49	0.99	0.25	0.49	1.48	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	55.55	13.06	0.27	0.82	0.96	0.14	2.34	0.00	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	89.09	10.61	1.29	1.61	0.96	0.32	0.64	0.32	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	71.21	11.56	0.61	0.91	0.91	0.00	1.22	0.61	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	55.01	11.20	0.56	0.70	0.98	0.42	2.24	0.42	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	78.22	16.00	0.36	1.42	0.71	0.36	1.42	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	68.84	10.18	0.00	0.48	0.00	0.00	0.97	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	62.40	10.74	0.47	0.47	0.93	0.16	2.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	87.02	15.04	0.72	1.07	0.36	0.36	1.79	0.72	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	69.58	12.41	0.33	0.00	0.33	0.33	1.31	0.33	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	62.39	14.60	0.47	0.71	1.41	0.94	1.65	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	83.78	20.91	1.11	0.50	0.87	0.37	1.36	0.25	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	85.03	14.60	0.00	0.77	0.51	1.02	1.02	0.00	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	59.97	14.92	0.90	0.60	0.00	0.00	2.69	0.30	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	179.01	90.64	4.53	2.27	4.53	2.27	4.53	2.27	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	161.86	84.38	0.77	3.84	4.60	2.30	2.30	0.00	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	161.81	80.16	2.23	2.23	4.45	0.00	3.71	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	179.83	86.74	0.42	2.96	3.81	2.96	3.81	0.42	1.27	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	166.69	86.51	0.00	4.22	9.14	1.41	3.52	0.00	0.00	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	187.73	78.45	0.93	4.67	8.41	0.00	3.74	0.00	0.00	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	164.37	69.05	0.52	3.09	4.64	3.61	2.58	0.52	1.55	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	210.53	77.31	1.19	4.76	3.57	1.19	1.19	0.00	2.38	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	184.35	88.22	0.23	3.62	6.11	1.36	4.75	0.23	1.13	1.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	142.80	60.49	0.87	1.74	4.65	3.49	2.91	0.87	1.45	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	171.97	80.58	1.35	2.70	5.40	2.70	3.60	0.45	0.45	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	245.23	103.51	0.95	4.74	6.37	2.71	6.10	0.14	1.49	2.85
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	181.27	65.22	0.51	3.59	6.68	4.62	4.11	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	176.07	73.39	1.41	4.23	8.82	1.41	3.88	0.00	0.71	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	171.91	55.97	1.33	2.67	6.00	3.33	1.33	0.00	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	244.00	83.03	1.02	6.62	6.11	5.60	5.60	1.53	1.53	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	199.57	75.77	2.13	5.87	6.67	2.67	1.87	0.27	0.80	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	210.48	67.45	1.89	6.24	8.31	3.02	3.97	0.38	1.13	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	261.38	87.74	3.07	4.91	8.59	4.29	5.52	1.84	1.23	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	290.29	119.87	1.63	11.42	12.23	4.89	3.26	0.82	1.63	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	202.41	61.64	1.04	3.54	7.50	5.41	3.54	0.42	1.25	2.50
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	193.38	64.46	1.40	3.92	6.73	5.32	3.64	0.28	0.28	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	316.31	85.52	0.00	5.15	10.30	3.09	5.15	1.03	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	250.53	69.67	1.16	4.94	10.45	4.35	3.77	0.58	1.45	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	169.19	54.70	1.20	3.59	5.38	2.09	2.99	0.60	0.90	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	241.77	72.48	0.00	5.53	6.09	1.66	1.11	0.00	3.32	4.43
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	328.39	82.01	0.35	7.07	9.90	3.18	3.18	0.35	1.77	6.72
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	200.25	61.96	1.11	4.43	5.90	2.95	3.32	0.37	2.21	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	255.58	80.59	2.30	2.30	8.06	4.61	3.45	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	285.13	97.86	1.15	8.44	9.21	2.69	5.37	0.38	1.15	4.99
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	211.17	71.33	2.83	5.66	6.79	5.10	2.83	1.13	1.13	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	243.68	77.94	2.46	7.38	6.56	2.46	3.28	1.64	2.46	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	290.11	83.60	1.36	6.78	4.52	3.62	5.87	0.90	2.26	4.97
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	188.15	69.66	0.72	6.46	5.75	2.87	2.15	0.72	2.87	4.31
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	244.98	76.18	0.75	8.22	8.22	0.75	2.24	0.75	1.49	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	248.60	76.55	0.74	5.20	6.32	5.20	5.57	0.00	0.74	5.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	164.98	49.97	0.86	4.74	5.60	1.72	4.31	0.86	0.43	3.88
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	229.49	87.34	0.86	5.14	5.14	2.57	3.43	0.00	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	234.22	80.96	1.33	6.66	4.33	4.33	4.66	0.67	1.33	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	236.50	76.02	3.62	6.64	3.62	5.43	7.84	0.60	1.81	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	236.76	105.23	0.71	7.11	7.11	0.71	4.98	0.00	0.71	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	228.92	81.12	1.03	6.19	8.25	3.44	5.50	0.69	1.37	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	217.38	77.83	3.22	3.22	3.22	6.44	3.22	0.54	2.15	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	248.47	105.04	0.67	5.39	4.04	4.04	5.39	0.67	2.02	7.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	261.88	77.04	2.59	5.93	4.44	4.82	6.67	1.11	2.96	2.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	251.19	79.08	2.33	5.81	4.65	1.16	4.65	1.16	1.16	4.65
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	257.03	107.89	1.06	3.17	4.23	2.12	5.29	1.06	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	268.10	81.23	1.20	6.80	6.40	3.20	3.20	1.60	1.20	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	186.08	100.31	0.00	2.91	3.63	2.91	3.63	0.00	0.73	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	282.08	102.71	2.30	4.60	9.96	1.53	6.13	0.00	2.30	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	235.29	101.62	0.49	4.44	10.36	5.43	3.95	0.00	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	219.24	74.33	0.94	4.70	4.70	0.94	3.76	0.00	2.82	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	268.51	120.68	0.50	4.02	13.07	4.02	6.03	1.01	1.01	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	269.02	96.88	2.70	5.41	8.56	4.06	2.70	0.45	2.25	4.06
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	239.23	92.94	1.72	3.44	6.88	5.16	5.16	0.00	1.72	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	279.68	119.35	2.23	4.01	12.47	1.78	6.23	0.45	0.89	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	264.33	96.97	1.96	5.47	9.38	3.52	6.65	0.00	1.56	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	213.09	71.25	0.66	5.28	8.58	3.96	5.28	0.66	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	299.42	99.11	1.56	5.19	10.38	4.15	8.82	0.52	0.52	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	300.17	95.83	1.75	2.63	6.56	4.38	4.81	0.44	1.75	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	284.58	82.19	1.68	4.47	6.71	5.03	2.24	1.12	2.24	4.47
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	398.80	90.98	2.21	7.95	8.39	4.86	4.42	0.44	2.21	3.97
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	305.87	99.90	1.16	8.10	10.41	5.01	3.86	0.39	1.54	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	374.20	83.04	4.05	7.09	5.57	4.05	4.56	0.51	1.52	4.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	477.74	94.20	5.29	12.02	7.69	4.33	4.33	1.44	3.84	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	338.31	90.64	3.18	9.14	9.54	6.36	5.96	0.40	1.99	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	375.51	80.81	4.86	9.72	7.90	6.08	4.25	0.00	3.04	6.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	421.94	75.40	4.84	5.53	6.92	2.08	5.53	0.00	0.69	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	455.61	87.78	5.70	11.40	9.88	7.22	7.22	3.04	3.04	3.04
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	451.86	96.05	8.78	6.71	12.91	9.81	5.68	1.03	3.10	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	498.84	83.44	1.81	8.47	9.67	4.84	3.63	1.21	2.42	6.05
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	441.44	78.27	3.80	9.19	9.19	6.02	6.97	0.95	3.49	2.22
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	463.25	85.29	5.33	8.53	11.19	2.67	6.93	2.67	5.33	8.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	505.71	96.54	5.75	8.05	9.77	4.02	6.32	0.57	0.57	8.62
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	530.69	91.02	6.17	6.69	13.88	11.83	3.60	1.03	3.09	9.26
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	427.24	75.69	6.37	4.95	10.61	4.24	2.12	1.41	4.24	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	473.28	99.31	3.97	5.67	6.81	4.54	4.54	1.13	3.40	6.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	465.53	91.94	4.16	11.23	9.57	9.57	5.82	2.08	0.00	7.07
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	406.40	72.82	6.26	5.48	14.09	8.61	7.05	3.92	9.40	6.26
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	392.49	81.42	2.51	7.10	7.52	4.18	4.18	0.42	1.25	7.10
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	458.60	79.45	4.18	7.43	11.15	9.29	4.65	2.79	4.18	6.04
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	363.96	79.62	5.35	5.35	8.03	2.01	2.01	2.01	1.34	4.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	382.27	87.68	1.07	6.95	5.35	4.28	6.95	0.00	2.14	6.42
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	434.81	87.69	5.25	4.04	9.70	7.68	6.47	2.83	1.62	6.47
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	340.49	95.45	6.42	8.26	2.75	3.67	0.92	1.84	0.92	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	435.66	94.25	1.78	0.89	7.11	6.22	3.56	0.00	2.67	7.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	474.13	94.03	1.14	8.55	9.69	3.42	4.56	0.57	1.14	5.70
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	362.74	81.29	2.30	4.60	9.20	5.37	6.90	0.77	3.07	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	293.29	87.55	1.09	3.28	6.57	1.64	5.47	1.09	2.74	3.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	398.68	89.53	1.34	7.13	8.91	2.67	4.01	0.00	2.23	4.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	384.21	89.68	1.82	5.72	5.46	3.90	6.24	2.34	1.56	5.20
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	307.68	100.79	3.98	2.65	4.64	2.65	8.62	0.00	1.33	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	503.02	112.24	6.24	6.24	6.24	6.24	2.08	4.16	6.24	0.00
Macrophage - monocyte derived, donor1	11232-116C8	276.46	19.60	4.33	1.37	0.91	1.37	0.68	0.46	1.14	0.23
Macrophage - monocyte derived, donor2	11313-117C8	445.19	15.60	12.29	2.75	3.12	3.12	0.18	1.10	3.12	1.65
Macrophage - monocyte derived, donor3	11389-118C3	397.18	16.78	8.91	3.54	1.97	2.23	0.26	2.36	2.62	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	63.19	22.30	0.53	0.53	1.59	0.53	0.53	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	60.85	14.10	0.63	0.16	0.32	0.48	0.95	0.32	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	60.32	11.81	0.69	0.00	0.14	0.14	0.42	0.28	0.00	0.42
Mammary Epithelial Cell, donor1	11273-116H4	274.32	58.59	2.39	0.70	2.09	2.59	0.20	1.30	2.29	1.10
Mammary Epithelial Cell, donor2	11350-117G9	324.87	53.86	3.47	1.16	2.32	1.16	0.00	1.74	0.87	1.16
Mammary Epithelial Cell, donor3	11422-118F9	149.91	16.96	1.00	1.75	0.50	0.25	0.00	1.25	0.75	0.25
Mast cell - stimulated, donor1	11487-119E2	84.06	18.98	1.36	0.68	3.39	1.36	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	56.67	59.80	0.22	0.43	4.87	0.76	1.51	0.32	0.11	0.43
Mast cell, donor2	11565-120D8	124.81	46.95	1.49	1.19	2.67	2.67	2.38	2.38	0.00	0.89
Mast cell, donor3	11566-120D9	156.69	71.36	0.90	3.15	3.60	6.08	3.38	1.35	0.90	0.90
Mast cell, donor4	11567-120E1	126.41	48.22	0.71	1.60	1.95	6.03	2.66	0.71	0.53	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	60.44	25.84	0.22	0.11	2.88	0.67	0.44	0.33	0.22	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	192.62	50.78	4.67	2.33	8.17	8.17	0.58	0.58	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	13.54	55.18	0.11	0.11	1.38	0.34	0.46	0.11	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	41.34	69.12	0.17	0.00	2.68	0.84	0.84	0.50	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	61.19	14.53	0.20	0.40	1.49	0.00	1.29	0.30	0.20	0.30
Melanocyte - dark, donor2	11582-120F7	180.66	16.96	1.38	2.77	0.69	0.35	1.38	0.35	1.04	1.04
Melanocyte - dark, donor3	11663-122F7	56.94	14.13	0.36	0.58	0.87	0.29	1.30	0.29	0.36	0.22
Melanocyte - light, donor1	11274-116H5	134.70	22.57	0.94	1.18	0.24	3.76	2.59	0.94	0.00	0.71
Melanocyte - light, donor2	11351-117H1	81.21	13.65	0.00	0.00	0.00	0.68	0.00	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	98.86	14.74	3.47	0.87	1.73	0.00	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	61.95	12.29	0.52	0.73	0.21	0.62	0.73	0.10	0.00	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	51.10	12.37	0.00	0.81	0.27	0.00	2.96	0.27	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	50.09	25.18	1.07	0.54	0.54	0.27	1.07	0.27	0.27	0.27
Meningeal Cells, donor1	11493-119E8	189.07	23.32	1.12	1.36	0.62	0.50	1.61	0.25	0.87	1.12
Meningeal Cells, donor2	11573-120E7	148.77	13.64	0.88	1.76	0.44	0.00	2.20	0.00	0.88	1.76
Meningeal Cells, donor3	11654-122E7	103.59	13.37	0.90	0.90	0.49	1.06	0.73	0.41	0.16	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	79.84	13.97	0.57	2.57	0.57	0.57	0.57	1.14	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	56.66	15.30	0.70	0.91	1.81	0.50	0.70	0.20	1.01	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	540.12	106.45	0.00	5.26	5.26	5.26	1.31	0.00	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	209.31	20.93	0.00	1.31	2.62	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	136.35	17.22	2.87	0.72	0.00	1.44	0.72	2.15	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	180.00	23.08	1.69	2.54	2.12	1.48	0.64	0.85	1.27	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	95.50	15.08	1.51	0.50	0.50	1.51	0.00	1.51	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	117.79	19.12	0.66	1.76	2.20	0.44	1.32	0.44	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	30.68	13.15	0.73	0.73	2.19	0.00	2.92	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	84.09	16.16	0.20	1.23	1.23	0.61	0.82	0.00	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	88.23	12.74	0.28	0.97	0.83	0.28	1.66	0.14	0.55	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	664.64	43.86	7.43	4.83	1.86	1.86	1.86	1.49	1.86	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	249.73	21.84	2.24	2.63	1.05	2.76	1.18	1.05	1.58	1.84
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	370.63	59.35	2.97	4.45	1.78	1.48	0.30	1.48	2.37	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	366.68	53.72	4.67	7.01	0.00	0.00	2.34	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	88.38	14.73	1.28	5.12	1.92	0.00	0.00	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	187.50	22.68	1.06	0.71	1.06	0.35	1.42	1.77	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	274.26	22.83	2.19	2.19	1.56	2.81	1.56	1.56	1.88	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	158.20	14.51	0.00	2.90	0.00	0.00	0.73	0.00	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	341.02	31.82	6.63	1.86	0.80	2.92	0.80	3.18	4.51	0.80
Mesothelial Cells, donor2	12156-128G5	182.67	31.03	3.00	0.00	0.00	2.00	0.50	1.00	3.50	3.00
Mesothelial Cells, donor3	11402-118D7	239.70	16.55	4.05	1.66	0.51	1.08	0.87	1.01	3.76	2.02
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	49.96	18.90	1.35	1.35	2.70	1.35	0.00	0.00	6.75	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	158.85	17.98	5.66	2.22	0.99	1.48	1.48	0.74	3.69	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	257.36	13.25	8.24	2.36	2.65	0.88	0.88	3.83	1.18	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	96.80	10.37	3.46	0.00	0.00	0.00	3.46	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	132.66	16.43	3.10	0.31	0.00	2.48	0.31	1.55	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	224.44	13.07	8.50	2.90	1.87	0.41	0.21	1.45	2.28	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	53.27	2.32	6.95	0.00	2.32	0.00	0.00	0.00	4.63	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	338.35	23.52	6.76	3.00	3.25	2.00	0.25	1.25	1.75	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	200.16	14.90	6.52	1.86	2.33	2.33	0.47	1.86	2.33	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	314.78	20.93	7.72	1.22	1.83	1.02	0.41	2.24	2.03	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	236.39	18.61	11.88	2.38	1.19	1.58	0.40	1.58	3.17	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	265.48	13.27	0.88	1.77	1.77	2.65	0.00	0.88	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	294.07	20.90	11.78	1.90	2.66	1.52	0.38	2.28	2.66	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	73.69	11.84	1.32	0.00	2.63	0.00	0.00	0.00	5.26	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	230.90	18.04	6.37	2.33	0.64	2.76	0.00	1.49	2.33	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	92.08	11.97	9.21	0.92	0.00	1.84	0.00	1.84	3.68	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	265.87	11.92	4.47	2.98	1.19	1.19	0.89	0.30	2.09	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	33.53	5.03	1.68	1.68	1.68	0.00	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	246.39	16.56	6.02	3.26	1.00	2.01	0.50	1.51	1.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	184.19	9.51	8.08	1.90	2.38	0.48	0.24	1.66	2.38	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	98.41	4.42	2.76	1.66	0.00	0.55	0.00	1.11	2.21	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	368.16	14.51	10.36	2.53	1.84	2.99	1.15	0.92	4.14	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	213.49	14.51	7.78	1.68	0.42	1.26	0.21	2.31	1.89	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	331.63	9.99	8.36	2.45	1.63	0.41	0.41	2.45	2.45	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	315.37	17.81	5.79	3.65	1.07	2.36	0.21	1.72	1.29	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	205.40	12.00	7.11	2.22	0.89	2.45	0.00	1.78	2.45	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	348.89	15.11	6.13	3.94	0.88	1.10	0.00	2.19	1.53	1.97
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	113.56	7.10	4.06	4.06	0.51	1.01	0.00	0.00	3.04	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	101.08	6.63	3.31	1.66	1.66	1.66	0.00	0.00	6.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	325.33	9.24	3.26	3.26	0.27	2.45	0.82	2.99	1.63	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	220.27	10.00	9.12	2.94	0.29	1.18	0.29	0.29	2.35	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	119.94	15.26	3.27	0.00	3.27	6.54	0.00	1.09	7.63	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	580.99	20.18	9.61	3.84	0.96	3.36	0.00	3.84	2.40	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	317.38	14.81	8.00	5.60	1.20	4.00	0.80	3.20	4.40	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	117.92	2.74	2.74	2.74	1.37	1.37	0.00	0.00	2.74	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	766.88	25.53	18.02	6.01	1.50	3.50	0.00	3.00	3.00	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	485.05	0.00	26.95	0.00	0.00	0.00	0.00	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	118.23	10.19	4.08	0.00	0.00	0.00	0.00	0.00	6.12	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	691.92	19.71	17.08	1.31	0.44	2.19	0.44	5.26	2.63	2.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	102.64	12.14	6.62	2.21	0.00	0.00	0.00	1.10	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	163.30	5.76	7.04	1.92	0.64	1.92	0.00	0.64	5.12	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	732.85	21.07	15.62	2.98	1.24	3.72	0.99	3.22	6.20	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	133.61	12.53	7.65	4.18	0.70	1.39	0.70	0.70	2.09	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	159.11	0.00	6.63	4.42	6.63	2.21	0.00	0.00	15.47	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	804.43	20.17	18.12	1.37	0.34	8.89	1.71	5.13	3.08	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	191.68	6.56	10.07	1.31	0.44	0.00	0.44	0.00	1.75	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	221.58	7.46	5.68	1.42	0.71	1.42	1.07	2.13	5.33	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	651.16	25.81	12.62	3.09	1.40	4.21	0.84	2.81	3.37	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	286.37	9.14	8.31	2.91	1.66	0.42	0.83	0.83	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	134.61	6.41	3.50	2.33	0.58	2.91	0.00	0.58	6.99	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	646.77	23.23	13.88	5.13	1.21	4.52	0.30	3.02	4.52	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	444.94	12.52	11.69	6.26	1.67	2.09	0.42	0.42	2.09	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	173.25	21.66	14.44	7.22	0.00	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	420.22	14.78	5.54	0.92	0.00	3.69	0.00	1.85	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	340.33	7.40	10.24	3.41	1.14	1.71	0.00	1.14	4.55	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	332.05	6.49	6.49	2.35	0.28	0.41	0.69	2.76	1.80	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	587.49	21.25	9.59	2.59	0.78	1.55	0.78	5.70	2.85	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	312.29	10.30	7.72	5.15	0.86	0.86	0.00	1.72	1.72	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	130.85	6.99	6.35	3.18	0.64	0.00	1.27	0.64	8.26	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	379.78	11.21	8.01	2.94	0.27	2.40	1.33	1.60	3.20	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	554.06	17.36	10.18	4.19	0.60	2.69	2.10	1.20	3.29	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	320.79	6.22	6.22	1.55	0.71	1.84	0.99	2.26	2.54	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	656.46	18.47	12.42	2.55	1.59	1.59	1.27	4.46	2.23	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	436.07	11.94	11.06	7.30	1.11	1.33	0.66	1.99	1.99	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	216.14	6.07	4.93	2.28	1.52	0.76	2.65	3.41	4.55	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	496.05	17.33	9.09	2.84	0.85	4.83	1.14	3.69	4.26	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	558.47	19.42	10.08	13.03	1.97	1.97	0.74	1.97	2.21	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	155.75	7.17	5.87	1.30	1.30	2.61	0.65	5.21	2.61	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	471.33	19.11	8.53	2.94	1.18	5.29	1.47	4.12	3.82	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	611.25	14.70	13.84	6.34	2.02	2.02	0.86	1.44	4.32	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	394.42	17.31	8.24	0.41	2.06	3.30	0.41	2.06	2.06	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	518.44	17.57	8.04	0.60	0.89	2.38	1.19	2.38	3.28	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	116.77	33.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	106.94	12.48	0.00	0.00	1.78	1.78	0.00	1.78	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	162.31	20.04	2.63	0.99	0.00	0.66	0.00	1.97	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	213.55	18.94	1.05	0.00	4.21	1.05	1.05	0.00	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	141.94	23.33	2.37	0.79	1.38	1.78	0.79	0.40	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	241.21	26.08	8.38	1.86	0.93	1.86	0.00	0.00	2.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	182.88	24.03	2.25	1.88	0.75	0.75	1.50	1.88	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	281.52	22.11	9.06	2.40	1.60	0.80	0.80	0.80	2.66	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	237.96	15.38	2.71	0.79	0.34	2.26	1.24	0.79	0.68	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	223.96	19.15	4.42	1.47	2.21	1.47	1.47	1.47	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	174.42	16.49	1.47	1.47	1.10	1.10	0.37	1.47	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	244.23	23.33	12.44	3.11	3.11	6.22	0.00	3.11	3.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	118.11	13.90	3.21	1.60	0.53	0.53	0.53	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	139.10	3.86	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	283.79	31.31	7.07	2.02	0.00	2.02	1.01	5.05	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	75.47	14.76	4.64	2.95	1.26	0.42	0.42	0.42	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	235.62	9.53	1.36	0.00	0.00	1.36	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	41.96	1.91	1.27	0.00	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	31.58	4.05	0.00	0.00	0.00	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	63.44	1.51	0.00	0.00	1.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	885.08	45.68	11.42	0.00	0.00	5.71	5.71	0.00	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	518.73	13.05	0.00	0.00	0.00	3.26	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	375.45	23.76	9.50	0.00	0.00	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	288.63	0.00	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	87.25	30.81	1.72	0.65	2.15	0.86	0.86	1.08	0.86	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	141.63	22.47	0.52	2.61	2.09	0.52	1.05	0.52	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	38.71	8.01	1.33	2.00	1.33	1.33	0.00	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.27	5.43	0.00	1.25	4.17	0.83	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	23.58	8.56	0.19	0.19	0.76	0.76	0.00	0.00	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	25.53	7.98	0.00	1.60	1.60	0.00	1.60	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	6.12	0.00	0.00	0.00	0.68	1.36	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	14.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	45.20	7.12	1.26	0.84	1.67	1.26	2.93	0.42	1.67	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	25.57	7.90	0.70	3.02	0.93	0.00	2.09	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	35.94	4.32	0.81	1.35	1.35	1.08	1.89	0.27	0.54	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	76.53	8.20	0.63	1.26	1.05	0.63	1.68	0.21	1.26	1.68
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	55.67	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	68.99	12.91	0.99	1.49	1.49	0.50	1.49	0.00	1.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	56.57	14.35	0.81	0.81	1.35	1.08	1.89	0.00	1.35	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	43.07	12.01	0.68	1.59	3.40	1.13	1.13	0.45	0.68	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	47.19	6.86	0.33	2.61	2.29	0.33	2.94	0.16	0.98	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	99.33	10.21	0.91	1.46	1.46	1.09	1.28	0.91	0.91	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	78.50	12.20	1.59	1.59	3.71	0.00	1.59	1.06	0.53	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	78.04	10.21	1.20	2.40	2.40	0.60	0.60	1.20	1.80	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	41.35	8.20	1.31	0.33	1.31	1.97	0.00	0.00	1.64	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	46.02	12.36	1.14	1.63	3.58	0.16	0.98	0.16	1.30	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	75.84	7.94	0.18	0.71	1.59	1.06	1.23	0.71	1.41	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	96.34	9.14	1.41	0.70	4.92	0.70	1.41	0.70	4.22	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	43.67	11.03	0.00	2.30	3.22	0.00	2.76	0.92	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	69.41	9.96	1.61	2.89	1.29	0.32	2.89	0.00	1.93	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	62.42	14.14	2.07	1.03	1.72	3.45	0.00	0.69	3.79	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	12.64	0.00	2.53	0.00	0.00	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	78.64	7.57	1.78	0.67	1.78	0.67	0.67	0.67	2.23	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	47.84	7.62	1.69	1.69	3.39	0.00	0.85	0.00	1.69	2.54
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	30.62	6.65	0.47	0.47	1.19	0.24	1.42	0.71	1.19	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	75.12	9.87	0.86	0.86	3.43	0.43	2.15	0.86	1.72	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	62.98	8.33	1.67	1.00	1.33	0.67	1.67	0.00	0.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	73.49	4.96	0.45	1.35	0.90	0.45	0.90	0.45	0.90	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	34.52	9.13	0.79	0.79	2.78	0.00	0.79	0.40	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	63.15	12.07	0.93	2.79	3.71	0.00	2.79	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	58.27	6.05	0.38	0.76	1.51	1.51	1.89	0.38	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	48.56	5.87	0.33	2.28	2.28	0.33	0.65	0.98	0.98	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	48.37	4.79	1.74	1.31	1.31	0.00	0.87	0.44	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	37.54	3.62	0.00	1.36	1.81	0.45	0.90	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	44.98	4.41	2.65	2.65	1.76	0.00	2.65	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	71.14	7.31	0.00	1.99	2.66	0.00	2.66	0.00	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	76.89	5.46	1.98	2.48	1.98	1.49	0.99	0.00	0.99	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	41.73	4.21	0.00	2.68	1.91	0.38	1.91	0.00	1.15	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	110.70	11.49	0.91	2.12	1.21	1.21	1.81	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	78.02	8.40	1.55	0.44	1.77	0.44	1.11	0.22	1.55	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	42.69	6.10	0.00	4.07	3.39	0.68	1.36	0.68	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	20.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	74.38	7.93	0.61	0.61	4.27	1.83	3.05	0.61	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.35	3.78	0.63	1.57	3.46	0.31	1.26	0.00	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	46.31	6.05	0.00	2.42	2.42	0.61	0.91	0.61	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	58.54	11.08	1.58	2.37	0.79	0.00	0.79	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	55.55	21.54	1.13	1.13	2.27	1.13	1.13	2.27	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	15.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	75.66	18.39	1.61	0.75	1.24	0.37	0.62	0.25	0.62	0.37
Myoblast, donor2	11322-117D8	134.64	14.58	0.96	0.77	1.53	1.73	0.58	1.34	0.58	0.58
Myoblast, donor3	11398-118D3	119.56	12.44	0.84	1.01	1.51	0.34	0.50	0.67	1.18	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	115.58	76.76	1.46	0.73	3.50	0.58	0.88	2.19	0.73	0.88
Natural Killer Cells, donor1	11230-116C6	82.11	63.96	0.92	1.85	4.92	0.92	0.62	1.54	0.92	0.62
Natural Killer Cells, donor2	11311-117C6	59.41	64.53	0.60	1.51	2.11	0.90	2.41	1.51	0.60	0.30
Natural Killer Cells, donor3	11387-118C1	83.19	69.20	1.47	2.94	4.42	0.55	1.84	3.31	0.18	0.37
Neural stem cells, donor1	11275-116H6	20.69	4.36	0.36	0.36	1.09	0.73	1.81	0.00	0.00	1.45
Neural stem cells, donor2	11352-117H2	11.55	3.85	0.00	0.00	0.00	0.00	0.00	1.93	0.00	1.93
Neurons, donor1	11494-119E9	28.45	3.41	1.14	0.00	0.00	1.14	0.00	0.00	0.00	1.14
Neurons, donor2	11574-120E8	16.95	1.10	0.22	0.22	1.10	0.22	0.44	0.00	0.22	0.22
Neurons, donor3	11655-122E8	13.15	3.29	0.00	1.64	0.82	0.82	1.64	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	3380.72	381.41	35.26	103.94	12.06	33.41	13.92	27.84	6.50	6.50
Neutrophils, donor2	11314-117C9	2119.08	301.48	40.58	52.18	8.70	57.98	2.90	26.09	5.80	14.49
Neutrophils, donor3	11390-118C4	3102.47	499.06	30.54	95.29	8.55	14.66	11.00	22.60	9.77	9.77
Nucleus Pulposus Cell, donor1	11252-116F1	188.31	18.17	1.90	3.21	0.24	1.42	1.07	0.47	1.66	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	150.75	15.30	1.30	2.28	0.65	0.65	0.98	0.98	0.98	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	113.91	28.08	0.40	3.21	0.60	0.20	2.21	0.40	1.20	2.41
Olfactory epithelial cells, donor1	11933-125I7	94.02	10.74	1.38	1.79	2.75	0.41	1.79	0.28	0.83	1.38
Olfactory epithelial cells, donor2	11934-125I8	122.02	15.63	2.03	2.61	2.46	3.18	0.72	1.59	1.01	2.17
Olfactory epithelial cells, donor3	11935-125I9	74.35	16.00	0.57	1.25	3.18	0.34	1.02	0.34	0.68	0.45
Olfactory epithelial cells, donor4	11936-126A1	86.49	14.80	0.97	0.78	2.05	0.39	1.36	0.49	0.49	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	195.59	25.88	1.81	3.01	0.60	3.01	1.20	1.81	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	56.58	13.40	0.43	0.64	1.70	0.64	0.64	0.21	0.21	0.43
Osteoblast - differentiated, donor2	11353-117H3	102.88	40.01	3.43	2.29	8.00	1.14	2.29	0.00	8.00	4.57
Osteoblast - differentiated, donor3	11425-118G3	120.42	41.59	3.10	3.72	4.97	0.62	0.62	0.00	0.62	1.24
Osteoblast, donor1	11277-116H8	142.67	35.37	1.56	1.56	2.74	1.17	1.37	0.78	0.59	2.15
Osteoblast, donor2	11354-117H4	87.09	17.56	0.00	0.00	1.40	0.70	2.11	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	85.49	17.60	1.24	1.07	1.42	0.00	1.07	0.00	0.89	1.78
Pancreatic stromal cells, donor1	11249-116E7	144.72	21.73	1.85	1.01	0.42	1.18	1.26	0.59	0.84	1.01
Pericytes, donor1	11491-119E6	192.05	28.37	0.67	2.23	1.22	1.22	2.23	0.89	1.89	2.56
Pericytes, donor2	11571-120E5	86.25	17.88	0.91	2.49	2.26	0.45	2.04	0.23	0.23	0.91
Pericytes, donor3	11652-122E5	96.23	26.25	0.61	1.02	0.41	0.41	1.02	0.20	0.41	0.00
Perineurial Cells, donor1	11499-119F5	71.77	13.68	0.57	0.79	1.13	0.79	1.13	0.11	0.11	0.79
Perineurial Cells, donor2	11579-120F4	151.08	16.47	1.56	2.39	0.74	0.64	0.83	0.83	0.46	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	401.93	60.56	16.89	5.74	1.27	2.55	1.27	11.47	2.23	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	425.08	67.58	16.41	9.30	2.20	5.88	2.94	12.24	2.69	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	294.68	49.31	10.09	6.21	3.49	1.94	1.42	7.64	2.33	1.16
Placental Epithelial Cells, donor1	11278-116H9	107.86	29.42	0.48	0.96	1.20	1.20	0.72	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	161.90	31.05	1.11	2.22	2.22	3.33	4.44	0.00	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	100.13	22.58	0.98	1.57	0.39	0.79	2.36	0.79	0.39	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	171.83	35.44	2.22	0.95	2.53	5.70	1.58	1.27	0.32	0.95
Preadipocyte - breast, donor1	11467-119B9	151.76	25.14	2.63	1.13	1.69	2.25	0.75	1.31	1.69	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	138.23	25.32	1.04	0.26	2.09	1.44	0.39	1.04	0.65	0.78
Preadipocyte - breast, donor2	11328-117E5	138.47	31.07	0.68	1.35	3.60	2.25	3.15	0.90	0.90	0.68
Preadipocyte - omental, donor1	11468-119C1	273.54	25.25	4.90	1.28	1.70	3.52	1.92	1.70	2.66	1.60
Preadipocyte - omental, donor2	11329-117E6	149.27	25.75	4.36	0.44	1.75	2.18	0.87	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	171.33	19.77	2.58	1.29	2.01	1.58	0.72	1.00	0.43	0.57
Preadipocyte - perirenal, donor1	11469-119C2	229.33	11.81	2.95	1.97	0.98	1.97	1.97	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	132.06	27.64	0.61	0.61	1.23	0.61	0.61	0.31	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	152.11	16.47	1.59	1.42	0.89	0.89	1.24	0.89	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	168.07	16.35	1.70	1.19	2.55	2.72	1.53	0.68	1.02	1.53
Preadipocyte - visceral, donor1	11280-116I2	174.28	19.65	1.68	1.12	0.93	1.40	1.12	0.75	1.02	0.75
Preadipocyte - visceral, donor2	11357-117H7	136.67	24.85	1.84	0.92	1.38	1.38	0.46	0.92	1.38	0.92
Preadipocyte - visceral, donor3	11429-118G7	122.99	15.57	0.63	0.84	1.57	0.84	1.25	0.42	0.31	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	112.99	17.65	1.51	5.73	0.75	1.66	1.81	1.06	0.30	0.91
Prostate Epithelial Cells, donor2	11331-117E8	57.96	19.09	1.35	0.14	0.68	1.62	0.41	0.14	0.27	0.41
Prostate Epithelial Cells, donor3	11404-118D9	222.60	28.11	1.41	0.86	0.80	1.10	1.10	1.16	0.86	0.06
Prostate Stromal Cells, donor1	11254-116F3	133.95	23.46	1.82	1.14	1.25	1.82	1.03	0.91	0.68	0.23
Prostate Stromal Cells, donor2	11332-117E9	149.89	26.72	1.61	0.54	1.79	0.90	0.90	1.08	0.36	0.54
Prostate Stromal Cells, donor3	11405-118E1	178.73	29.72	2.40	3.02	3.23	2.61	0.94	0.83	1.15	1.25
Renal Cortical Epithelial Cells, donor1	11516-119H4	158.77	49.64	1.82	0.36	2.92	1.09	3.28	0.73	0.00	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	51.01	13.38	0.97	0.42	0.49	0.35	1.04	0.55	0.35	0.49
Renal Epithelial Cells, donor1	11517-119H5	122.75	28.91	0.51	3.04	0.00	0.00	2.54	0.00	1.01	1.52
Renal Epithelial Cells, donor2	11597-120H4	46.95	15.65	0.71	0.00	0.71	0.00	2.13	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	40.65	10.16	0.32	0.21	0.64	0.21	0.74	0.53	0.32	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	13.62	14.30	0.00	0.68	2.04	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	10.38	10.38	0.27	0.27	0.67	0.13	1.21	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.99	17.09	0.00	0.00	1.11	0.00	0.67	0.22	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	20.63	26.62	0.67	0.00	3.33	0.00	1.33	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	78.13	17.17	0.66	1.32	1.54	0.22	1.32	0.22	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	67.71	13.17	1.25	0.63	0.63	0.00	3.13	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	83.78	17.20	1.11	2.77	0.28	0.55	3.33	0.55	0.00	1.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	79.45	29.53	1.34	0.27	1.07	0.27	0.54	0.27	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	92.35	26.99	0.00	1.27	2.95	0.00	1.27	2.11	0.84	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	36.64	14.08	0.39	0.39	0.19	0.19	1.74	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	67.15	11.15	0.26	0.78	0.26	0.26	2.33	0.78	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	98.35	13.64	0.00	1.99	1.99	0.85	2.84	0.00	0.28	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	86.45	10.29	1.03	0.00	0.00	0.00	3.09	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	101.62	35.88	4.01	2.51	1.51	1.00	0.75	0.75	1.00	3.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	696.64	44.77	6.28	6.41	2.27	5.08	1.20	1.07	3.74	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	71.47	11.61	1.79	0.00	0.89	1.79	1.79	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	77.05	12.66	1.10	1.10	1.10	1.10	1.10	0.55	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	52.20	8.70	0.00	0.58	0.00	0.58	0.58	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	35.50	8.32	0.26	0.39	0.26	0.26	2.60	0.13	0.13	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	36.74	9.43	0.10	0.50	1.39	0.10	3.97	0.60	0.10	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	31.79	10.48	0.22	0.78	0.67	0.33	3.57	0.45	0.11	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	40.69	11.78	0.62	0.50	0.62	0.12	1.74	0.25	0.25	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	43.47	11.07	0.35	1.28	0.82	0.12	3.03	0.35	0.00	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	34.21	9.48	0.23	0.23	0.00	0.46	2.08	0.46	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	34.23	9.31	0.55	0.41	0.55	0.14	2.74	0.82	0.14	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	33.73	6.81	0.15	0.30	0.61	0.45	3.18	0.30	0.15	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	32.25	10.93	0.18	1.08	1.25	0.18	3.05	0.18	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	41.03	10.04	0.57	0.29	0.29	0.14	5.16	0.72	0.29	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	34.13	9.44	0.00	0.86	0.54	0.32	3.22	0.54	0.43	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	34.74	10.40	0.22	0.44	1.33	0.22	2.43	0.89	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	30.40	12.04	0.00	0.19	0.38	0.00	2.68	0.00	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	27.39	8.76	0.28	0.65	1.02	0.19	2.98	0.09	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	28.56	8.46	0.94	0.56	1.13	0.38	2.63	0.19	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	25.08	8.76	0.27	0.13	0.40	0.13	2.79	0.13	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	24.63	8.37	0.10	1.07	0.97	0.19	3.21	0.29	0.19	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	25.02	8.21	0.19	1.34	0.95	0.00	2.29	0.19	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	31.40	11.53	0.00	0.64	0.96	0.11	3.10	0.11	0.32	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	27.75	10.93	0.56	0.00	0.84	0.56	5.33	0.84	0.00	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	25.81	8.72	0.00	1.03	1.03	0.00	2.22	0.00	0.34	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	20.60	10.58	0.55	0.73	0.18	0.00	2.92	0.00	0.73	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	32.25	9.93	0.12	0.25	1.23	0.37	3.56	0.12	0.25	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	29.82	8.46	0.13	1.21	1.61	0.27	3.22	0.40	0.40	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	37.98	20.52	0.24	0.24	0.24	0.24	4.01	0.24	0.00	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	30.36	8.73	0.20	1.98	0.60	0.20	3.37	0.00	0.60	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	27.36	8.65	0.00	1.40	1.17	0.70	3.51	0.23	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	35.67	17.21	0.00	0.83	1.45	0.21	3.53	0.21	0.00	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	25.44	9.51	0.22	0.66	0.44	0.44	3.10	0.22	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	20.89	8.15	0.21	0.63	1.46	0.00	2.09	0.00	0.00	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	27.86	11.98	0.00	0.67	1.08	0.27	3.10	0.27	0.13	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	14.99	7.83	0.34	1.19	0.34	0.68	1.53	0.17	0.00	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	20.44	9.64	0.00	0.77	0.96	0.19	2.70	0.39	0.00	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	31.12	8.94	0.17	0.69	0.34	0.17	6.88	0.34	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.79	7.13	0.14	0.55	0.96	0.00	4.25	0.00	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	19.21	9.69	0.16	0.99	0.66	0.16	3.12	0.00	0.16	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	24.54	10.23	0.00	0.34	0.17	0.51	3.75	0.17	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	26.34	6.21	0.30	0.74	0.74	0.44	2.96	0.00	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	17.59	10.13	0.00	0.80	0.27	0.00	2.13	0.27	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	120.29	16.18	0.97	1.94	0.55	0.41	3.18	0.14	0.69	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.29	7.14	0.00	0.48	0.71	0.00	3.33	0.71	0.24	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	16.73	9.47	0.00	0.20	0.81	0.00	2.02	0.20	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	76.75	23.07	0.38	1.22	0.75	0.09	3.77	0.75	0.38	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	168.39	22.36	1.75	2.45	1.05	1.40	3.84	1.75	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	81.30	18.13	0.30	2.12	1.51	0.91	3.32	1.81	1.51	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	35.25	16.03	0.24	1.22	0.12	0.24	4.28	0.24	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	111.93	18.05	1.31	1.31	1.46	0.87	2.62	0.44	0.00	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	125.34	26.77	2.43	0.61	3.04	1.83	1.22	0.61	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	34.66	16.28	0.30	1.21	0.30	0.00	3.62	0.00	0.00	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	205.15	23.98	2.94	2.04	1.81	1.81	3.17	3.17	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	132.40	25.16	0.30	3.00	4.79	3.29	3.00	1.20	0.30	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	190.93	32.47	0.83	1.53	2.60	2.24	2.95	1.18	0.94	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	172.89	27.96	1.07	3.20	2.35	4.48	3.20	1.07	4.06	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	130.41	26.44	0.60	1.20	3.00	3.61	0.00	0.60	3.00	1.20
Schwann Cells, donor1	11498-119F4	114.72	19.18	0.56	0.94	1.50	0.56	2.07	0.38	0.19	1.69
Schwann Cells, donor2	11578-120F3	98.67	20.41	0.00	0.00	0.00	0.00	6.80	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	111.07	16.87	0.44	1.10	1.31	0.88	1.31	0.00	0.44	1.31
Sebocyte, donor1	11220-116B5	186.24	19.17	1.64	1.10	2.19	1.10	0.55	1.64	0.00	1.64
Sebocyte, donor2	11301-117B5	74.91	16.54	0.00	0.00	0.92	0.46	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	221.78	20.41	2.89	2.68	1.03	1.86	1.44	0.82	0.82	0.41
Sertoli Cells, donor1	11255-116F4	265.06	26.51	1.66	3.31	0.00	4.97	1.66	1.66	3.31	1.66
Sertoli Cells, donor2	11333-117F1	76.26	19.77	0.00	5.65	0.00	8.47	0.00	0.00	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	201.65	46.10	2.20	3.70	2.02	2.55	1.50	0.88	1.67	2.90
Skeletal Muscle Cells, donor2	11358-117H8	130.83	36.14	1.45	0.00	2.89	0.72	2.17	0.00	2.17	1.45
Skeletal Muscle Cells, donor3	11430-118G8	79.42	14.21	0.00	0.00	1.67	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	110.75	11.31	1.26	1.57	1.41	1.10	0.47	0.31	0.31	0.47
Skeletal Muscle Cells, donor5	11455-119A6	99.74	14.27	1.19	2.38	1.04	1.19	1.04	0.00	0.15	0.45
Skeletal Muscle Cells, donor6	11459-119B1	110.96	9.85	0.77	1.69	2.15	0.77	1.69	0.31	0.31	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	119.83	20.79	1.01	1.13	1.26	1.64	1.51	0.88	0.88	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	80.76	10.27	0.86	3.28	1.28	0.86	1.57	0.57	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	131.25	12.00	1.69	2.18	0.30	0.89	0.60	0.60	0.79	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	95.54	17.86	0.42	1.18	2.19	0.42	1.18	0.17	0.34	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	147.65	59.35	0.72	2.90	0.72	0.00	0.00	2.17	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	38.25	7.43	0.14	1.65	1.79	0.69	1.10	0.00	0.55	0.28
Skin - palm, donor1	10286-104F7	59.09	2.69	2.69	5.37	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	114.60	13.98	1.01	0.58	0.58	1.30	1.01	0.14	0.29	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	85.88	4.91	0.82	0.82	0.82	0.00	0.00	0.00	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	98.80	9.87	1.56	0.52	1.04	1.17	0.78	0.26	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	144.15	49.63	1.95	0.42	1.81	1.39	0.56	0.83	0.28	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	109.01	37.84	0.42	0.28	1.13	1.27	0.42	0.56	0.98	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	79.50	13.96	0.00	0.21	0.85	0.42	0.42	0.63	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	148.03	46.09	1.65	0.52	1.80	1.57	0.90	1.05	1.35	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	104.92	43.20	0.62	0.00	1.54	1.23	1.54	0.00	0.62	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	70.48	17.34	0.22	0.44	0.89	0.89	0.67	0.00	0.89	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	94.05	25.28	2.35	0.00	1.76	0.00	0.59	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	97.24	24.09	0.22	0.88	1.10	0.88	0.22	0.00	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	61.82	24.02	0.79	0.39	1.18	0.79	0.00	0.00	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	103.52	23.95	0.77	0.77	0.77	0.00	0.77	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	270.20	17.01	2.00	1.00	1.00	0.00	3.00	0.00	0.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	40.06	18.76	0.53	0.27	0.53	0.40	0.53	0.00	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	72.92	15.29	1.11	0.66	1.33	0.22	1.55	0.22	0.89	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	44.30	28.29	0.38	0.64	2.82	0.13	0.64	0.26	0.26	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	96.37	12.37	0.98	0.65	0.65	1.63	0.98	0.00	1.30	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	56.70	7.09	0.59	0.59	0.59	0.30	1.77	0.30	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	114.60	16.80	1.85	1.28	0.57	0.71	1.00	1.00	1.42	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	144.62	32.70	1.95	1.79	2.11	0.00	0.81	0.16	0.65	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	177.18	44.14	2.13	1.83	3.04	1.83	0.61	0.30	2.13	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	137.39	13.39	1.52	0.76	1.77	0.00	2.78	0.00	0.51	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	153.02	61.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	26.70	10.97	0.00	0.95	1.43	0.00	0.48	0.00	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	93.50	12.98	0.59	1.03	0.59	1.62	0.88	0.29	0.59	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	89.11	10.98	1.08	0.86	0.22	0.65	1.29	0.86	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	92.99	11.13	1.05	1.05	0.63	0.63	1.05	0.31	0.31	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	56.46	21.66	0.77	0.46	1.86	0.62	0.46	0.31	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	36.65	23.71	0.00	0.00	0.00	0.00	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	52.00	10.46	0.90	0.00	0.30	0.30	1.20	0.90	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	157.73	19.46	0.00	2.73	1.37	0.34	1.37	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	108.53	11.70	0.39	1.65	0.79	0.63	0.71	0.24	0.16	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	66.73	15.80	0.81	0.81	0.81	2.31	0.70	0.91	0.60	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	85.33	23.21	0.46	1.37	1.14	1.14	2.50	0.23	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	97.21	17.51	0.60	1.81	1.81	0.60	1.81	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	98.82	15.10	1.06	1.59	1.85	0.26	1.06	0.26	0.79	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	121.31	19.97	0.27	1.20	0.67	0.27	0.80	0.27	0.67	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	140.25	29.68	0.88	1.50	2.13	1.63	0.88	0.63	0.88	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	177.82	32.72	2.28	2.03	2.79	1.78	0.76	1.27	1.52	1.78
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	59.56	14.62	0.60	0.75	1.21	0.30	0.75	0.30	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	122.28	12.00	1.50	0.75	0.75	0.75	0.75	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	744.32	208.05	0.00	0.00	0.00	6.46	0.00	3.88	0.00	10.34
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	118.59	20.00	1.86	0.93	1.86	0.93	0.93	0.93	1.86	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	42.41	13.63	1.01	1.01	1.51	1.01	0.50	0.50	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	48.58	14.10	0.00	0.31	1.25	0.31	0.00	0.00	1.25	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	103.25	20.35	1.18	0.29	2.65	0.29	0.88	0.00	0.88	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	42.99	15.74	0.50	0.25	1.00	0.25	0.42	0.00	0.17	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	95.30	19.62	0.00	0.93	1.40	0.47	2.34	0.93	3.27	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	21.73	16.55	0.00	0.00	0.58	0.14	0.72	0.00	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	31.87	20.40	0.25	0.51	1.02	0.51	0.76	0.00	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	24.63	12.60	0.00	0.94	1.13	0.00	0.56	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	45.28	11.88	0.70	0.14	0.70	0.28	0.98	0.14	0.42	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	66.61	25.64	0.67	0.92	0.75	0.59	1.51	0.08	0.00	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	529.99	47.14	8.10	9.05	1.43	0.95	0.48	1.90	9.52	5.24
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	25.20	16.88	0.49	0.00	0.49	0.00	0.98	0.24	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	78.66	14.80	0.66	0.66	2.87	0.22	0.66	0.22	0.66	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	123.47	21.94	0.59	1.17	2.05	0.59	0.29	1.46	1.46	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	289.40	14.19	2.72	2.33	0.78	1.17	1.55	0.58	1.75	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	121.12	15.34	2.64	0.53	0.26	1.06	0.26	0.53	2.12	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	120.88	14.51	2.60	0.37	0.00	2.98	0.00	1.12	1.12	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	175.00	24.79	1.80	0.00	1.44	1.08	0.00	0.72	3.59	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	147.06	22.71	2.84	0.85	0.57	1.14	0.57	0.57	2.84	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	79.17	18.51	0.79	0.00	0.39	1.18	0.39	0.00	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	217.64	17.52	2.79	0.51	1.78	4.83	0.76	0.51	2.03	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	345.01	15.57	3.19	0.40	1.60	5.19	0.80	1.20	1.20	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	251.22	15.88	5.02	2.51	1.25	3.76	0.42	2.09	1.67	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	236.97	20.63	0.92	3.67	2.29	0.92	0.46	1.38	3.21	0.92
Synoviocyte, donor1	11291-117A4	126.24	7.74	2.69	0.17	1.35	1.51	0.67	1.01	0.34	0.67
Synoviocyte, donor2	11368-117I9	160.25	18.77	1.68	0.67	5.03	1.01	1.84	1.34	1.01	0.34
Synoviocyte, donor3	11440-118H9	168.23	14.07	2.01	2.01	1.12	1.56	1.34	0.00	0.67	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	162.59	17.87	1.79	1.79	0.71	1.07	1.07	0.71	0.71	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	271.54	79.28	1.98	1.98	1.98	3.96	1.98	0.00	1.98	9.91
Trabecular Meshwork Cells, donor3	11693-123A1	210.94	52.56	1.85	3.70	4.63	0.93	1.85	1.62	0.23	2.55
Tracheal Epithelial Cells, donor1	11292-117A5	154.05	33.76	1.79	0.79	1.00	0.36	0.29	1.15	0.43	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	109.40	17.78	0.39	1.55	1.16	0.39	0.77	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	109.38	44.09	1.15	0.57	2.29	0.00	0.00	0.57	0.57	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	708.87	41.46	5.54	8.86	1.72	4.06	2.34	1.85	2.83	1.48
Urethra, donor2	10319-105A4	55.75	12.59	1.80	5.40	3.60	0.00	1.80	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	113.44	19.92	1.06	0.00	1.06	0.53	0.27	0.27	0.00	0.53
Urothelial Cells, donor2	11600-120H7	93.73	20.43	1.20	0.40	0.80	0.00	0.00	0.00	0.80	0.80
Urothelial Cells, donor3	11681-122H7	139.36	19.71	0.92	0.23	0.46	0.46	0.69	1.60	0.00	0.46
Urothelial cells, donor0	11216-116B1	96.29	18.72	1.11	0.45	0.67	0.22	0.45	1.34	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	762.54	153.93	5.34	1.78	0.00	6.23	3.56	1.78	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	766.27	151.54	1.43	0.00	1.43	5.72	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	448.36	102.68	0.68	1.37	2.74	0.68	0.68	0.68	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	261.01	87.81	1.03	2.07	2.41	1.72	1.72	0.34	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	420.08	102.84	3.49	2.32	3.49	1.74	1.74	1.74	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	1092.26	155.14	2.08	3.12	2.08	10.41	5.21	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	760.85	132.16	1.84	2.75	0.92	4.59	1.84	0.00	3.67	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	370.64	93.12	1.83	1.83	0.00	4.56	1.83	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	13.32	10.61	0.49	0.86	0.74	0.37	1.60	0.49	0.00	0.37
Wilms' tumor cell line:HFWT	10597-108E3	36.96	13.20	1.76	7.92	0.88	2.64	1.76	0.88	1.76	7.04
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	76.53	12.01	1.96	1.68	1.12	0.56	3.63	1.68	0.56	0.84
achilles tendon, donor2	10292-104G4	386.44	28.93	10.33	8.27	2.07	8.27	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	12.24	20.14	0.51	0.00	1.27	0.25	1.02	0.00	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	14.16	23.68	0.23	0.23	0.23	0.00	0.23	0.46	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	75.50	48.55	0.24	1.42	3.09	0.71	1.42	0.36	0.12	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	30.75	19.32	0.27	0.27	1.90	0.54	1.63	0.27	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	21.64	21.08	0.28	0.56	0.28	0.00	0.56	0.28	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	42.93	21.99	0.21	0.00	0.85	0.63	0.63	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	69.96	35.66	0.54	1.63	2.18	0.27	0.54	1.09	0.27	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	18.95	26.00	0.44	0.00	0.88	0.00	0.44	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	15.11	29.40	0.00	0.41	1.23	0.00	0.82	0.00	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	7.38	16.70	0.00	0.00	1.94	0.00	0.39	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	63.85	25.39	0.37	0.37	1.10	0.18	0.74	0.37	0.37	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	11.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	16.27	13.48	0.00	0.00	1.63	0.00	0.23	0.23	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	5.95	27.18	0.52	0.00	1.55	0.00	0.26	0.00	0.00	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	27.18	29.81	0.00	0.00	1.17	0.29	1.17	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	60.42	22.77	0.00	0.00	1.86	0.46	0.46	0.93	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	62.10	18.10	0.82	1.23	0.82	0.82	0.41	2.06	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	4.60	11.36	0.00	0.31	0.31	0.00	2.76	0.31	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	17.07	21.34	0.00	0.00	0.43	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	10.01	26.69	0.00	0.00	0.30	0.30	0.30	0.61	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	24.55	30.09	0.24	0.24	0.72	0.00	0.48	0.00	0.00	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	55.24	28.96	0.22	0.67	0.00	0.22	1.11	0.00	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.01	4.34	0.00	0.33	0.33	0.00	0.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	16.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	12.81	28.25	0.00	0.38	2.26	0.00	1.51	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	8.72	15.70	0.87	0.44	2.62	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	9.37	0.00	1.87	1.87	0.00	0.00	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	40.03	26.61	0.47	0.24	1.88	0.00	0.94	0.71	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	401.29	22.65	4.34	5.27	0.93	4.03	0.93	1.24	2.79	0.62
adipose, donor1	10184-103D4	1.17	0.00	0.00	0.59	0.00	0.00	0.59	0.00	0.00	0.00
adipose, donor2	10185-103D5	16.63	3.24	0.00	1.22	1.22	1.22	2.03	0.00	0.00	1.22
adipose, donor3	10186-103D6	38.66	10.62	0.00	1.09	1.09	0.54	2.18	0.00	0.54	0.82
adipose, donor4	10187-103D7	78.87	17.34	0.00	1.73	0.00	6.93	2.60	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	9.78	6.31	0.32	0.16	1.89	0.32	1.74	0.16	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	185.52	18.19	0.00	3.64	0.00	0.00	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	18.81	22.55	0.13	0.00	0.80	0.53	0.13	0.00	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	43.59	17.51	0.71	2.50	1.07	0.00	3.57	0.00	1.07	0.71
amniotic membrane cells, donor1	12235-129G3	174.35	25.50	0.70	0.70	0.70	2.78	2.32	0.93	0.46	0.93
amniotic membrane cells, donor2	12236-129G4	45.31	32.46	0.34	0.34	0.68	0.34	2.70	0.68	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	72.18	15.91	0.88	1.18	0.29	0.29	1.47	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	117.39	7.11	3.56	3.56	3.56	1.19	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	70.97	10.75	1.42	2.23	8.11	0.20	2.84	0.20	0.61	0.41
amygdala, newborn, donor10223	10360-105E9	87.15	5.81	1.29	2.26	2.26	0.32	1.29	0.65	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	591.83	67.87	4.46	3.95	3.06	5.86	2.29	2.55	2.67	5.86
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	431.32	9.27	5.07	2.43	1.54	1.32	1.10	3.09	1.32	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	24.38	1.34	0.33	1.00	1.34	0.00	1.34	0.00	0.00	0.67
aorta, adult, pool1	10052-101G7	144.35	20.59	1.18	6.28	6.47	0.59	5.30	1.37	0.00	1.37
appendix, adult	10189-103D9	91.98	20.57	0.78	0.78	1.94	4.66	1.16	0.78	1.16	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	7.57	2.06	0.00	0.00	0.34	0.00	2.75	0.00	0.00	0.00
artery, adult	10190-103E1	328.80	12.23	4.08	9.51	2.72	14.95	8.15	2.72	4.08	2.72
astrocytoma cell line:TM-31	10425-106D2	85.18	6.66	0.43	1.88	0.87	0.87	1.16	0.29	0.29	0.72
b cell line:RPMI1788	10427-106D4	22.60	12.19	0.15	0.00	0.45	0.15	0.15	1.04	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	101.82	25.80	0.00	0.55	0.55	1.66	0.55	1.66	0.83	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	140.81	31.75	1.89	0.30	1.49	0.69	0.20	2.98	0.50	1.39
bile duct carcinoma cell line:TFK-1	10496-107C1	284.38	29.12	3.18	1.84	1.17	2.51	1.17	1.67	1.67	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	80.53	36.91	0.56	1.68	1.12	0.00	1.12	0.56	0.56	0.00
bladder, adult, pool1	10011-101C2	220.22	20.42	2.17	3.59	2.93	2.06	1.63	1.30	1.09	1.30
blood, adult, pool1	10053-101G8	487.22	57.58	13.29	6.64	2.21	0.00	0.00	2.21	4.43	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	29.12	5.14	0.00	0.00	0.86	0.00	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	332.69	17.55	2.70	5.40	0.00	2.02	0.00	0.00	0.67	2.02
brain, adult, donor1	10084-102B3	25.63	15.38	0.00	1.03	5.13	0.00	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	55.79	6.01	0.89	1.00	3.34	1.00	1.22	0.45	0.22	0.89
brain, fetal, pool1	10085-102B4	13.36	5.34	0.00	0.00	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	59.47	56.49	2.31	3.63	7.60	1.98	1.98	1.65	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	47.56	23.09	0.50	1.62	1.37	0.37	2.37	0.25	0.25	0.00
breast, adult, donor1	10080-102A8	198.25	14.52	0.63	3.79	1.26	1.26	0.63	2.53	1.26	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	81.05	35.57	1.02	1.40	3.68	0.38	1.27	0.25	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	41.13	10.51	0.00	0.00	0.62	0.31	0.31	0.31	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	47.43	16.58	2.07	0.00	1.38	0.69	0.23	0.92	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	58.58	26.39	0.73	3.15	2.42	1.69	6.05	0.97	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	56.89	5.64	0.47	2.35	0.94	0.94	4.23	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	90.90	29.10	1.31	1.20	0.88	0.22	1.53	0.44	0.55	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	126.12	8.24	1.27	7.29	1.27	0.95	0.63	2.54	0.00	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	88.90	23.96	0.27	5.59	0.80	0.53	4.26	0.80	0.00	2.13
caudate nucleus - adult, donor10196	10177-103C6	153.13	5.76	2.30	2.30	3.45	0.00	1.15	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	74.46	12.38	0.84	2.34	8.37	0.00	1.67	0.17	0.50	0.33
caudate nucleus, adult, donor10258	10379-105H1	29.04	9.17	0.76	0.76	4.58	0.00	1.53	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	52.01	4.76	0.00	0.73	1.10	1.10	1.46	0.73	1.10	0.37
cerebellum - adult, donor10196	10173-103C2	55.35	2.91	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	30.32	5.98	0.43	1.07	1.49	0.00	0.85	0.00	0.00	0.43
cerebellum, adult, pool1	10083-102B2	12.42	2.07	0.00	0.69	0.69	0.34	1.38	0.34	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	22.42	3.32	0.00	0.00	0.00	0.83	0.83	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	71.10	13.62	0.76	1.76	6.56	0.50	2.27	0.25	0.25	0.50
cerebrospinal fluid, donor2	10294-104G6	86.98	8.77	0.73	0.73	2.19	1.46	0.73	0.73	3.65	0.00
cervical cancer cell line:D98-AH2	10552-107I3	141.19	27.17	1.15	1.73	3.02	0.72	0.43	1.58	0.43	1.01
cervical cancer cell line:ME-180	10553-107I4	280.89	21.54	1.99	0.83	2.32	1.99	0.66	1.16	0.50	0.33
cervix, adult, pool1	10013-101C4	205.99	22.89	1.26	7.24	3.04	4.72	4.51	0.52	0.73	2.62
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	480.72	85.14	7.25	2.93	4.18	5.29	2.51	4.88	6.69	11.15
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	5.23	1.31	0.00	1.31	0.00	2.61	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	383.64	27.46	6.34	2.98	1.37	5.47	4.72	5.22	2.61	6.46
choriocarcinoma cell line:SCH	10785-110H2	138.86	27.60	3.45	4.07	1.97	0.86	2.09	1.23	1.36	2.96
choriocarcinoma cell line:T3M-3	10618-108G6	204.21	14.94	1.66	0.00	1.19	2.13	3.79	1.42	1.19	3.32
chorionic membrane cells, donor1	12238-129G6	445.04	30.20	2.85	0.28	1.42	5.98	2.28	1.99	2.28	0.85
chorionic membrane cells, donor2	12239-129G7	173.91	45.24	2.09	1.59	0.89	1.49	0.70	0.60	1.09	1.09
chorionic membrane cells, donor3	12240-129G8	329.14	46.71	2.20	0.55	0.00	2.75	2.75	2.75	3.30	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	19.19	0.00	0.00	0.00	0.00	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	20.36	10.57	0.00	0.38	1.73	0.19	0.19	0.00	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.29	13.52	0.00	0.42	2.11	0.00	0.63	0.00	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	25.17	21.83	0.51	0.00	1.54	0.26	0.26	0.77	0.26	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	24.91	23.46	0.48	0.73	0.97	0.00	0.97	0.48	0.24	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	29.73	20.77	0.61	1.22	0.61	0.00	0.61	0.61	0.00	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	26.21	21.20	0.29	0.59	2.06	0.00	1.18	0.00	0.00	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	25.80	17.20	0.26	0.00	1.30	0.00	1.04	0.26	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	103.32	20.80	2.06	0.91	1.83	1.60	2.06	1.83	0.91	1.83
clear cell carcinoma cell line:TEN	10636-108I6	195.54	21.34	3.47	1.04	1.04	2.95	2.78	1.56	0.87	1.39
colon carcinoma cell line:CACO-2	10513-107D9	71.94	18.30	1.65	1.28	0.55	0.18	2.93	1.65	0.55	0.73
colon carcinoma cell line:COLO-320	10420-106C6	129.99	19.00	0.76	2.28	1.90	1.14	4.56	1.90	0.00	2.28
colon, adult, donor1	10082-102B1	27.37	20.23	0.00	0.00	2.38	0.00	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	217.50	25.03	1.76	3.64	1.88	4.82	1.88	0.24	0.71	1.18
colon, fetal, donor1	10070-101I7	43.26	12.36	0.62	3.71	1.85	0.00	0.62	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	73.34	13.75	0.00	4.58	9.17	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	75.11	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	169.55	21.67	2.12	0.42	3.82	1.27	0.00	1.27	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	78.94	16.90	0.60	0.00	2.26	2.72	0.30	0.60	0.45	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	55.42	11.70	0.85	0.28	2.12	0.42	0.42	0.56	0.00	0.42
corpus callosum, adult, pool1	10042-101F6	72.42	10.39	0.33	1.99	1.11	0.66	2.21	0.33	0.11	1.11
cruciate ligament, donor2	10295-104G7	240.71	14.59	3.24	4.05	2.43	0.00	2.43	0.81	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	44.94	7.22	0.00	3.21	5.62	0.80	2.41	0.00	0.00	0.00
diencephalon, adult	10193-103E4	24.72	5.04	0.00	1.20	2.88	0.24	1.44	0.00	0.00	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	6.66	21.35	0.23	0.00	0.92	0.00	0.69	0.46	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	221.82	53.85	3.33	1.03	2.82	1.28	1.28	1.03	0.77	2.31
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	94.36	35.63	3.37	5.54	1.44	0.24	0.24	1.20	0.24	0.72
ductus deferens, adult	10196-103E7	62.79	19.44	0.00	3.99	2.99	1.00	3.99	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	8.64	0.00	2.88	1.44	0.00	2.88	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	64.00	13.98	1.47	1.47	0.00	0.74	1.47	0.00	0.74	0.00
dura mater, adult, donor1	10041-101F5	175.33	23.04	4.13	4.71	1.24	1.90	2.31	3.22	0.99	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	279.59	50.41	2.00	0.44	4.89	5.11	0.89	3.78	0.89	4.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	14.90	10.89	0.14	0.72	0.14	0.00	1.72	0.14	0.14	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	91.88	25.28	4.32	1.23	3.70	0.62	4.93	1.23	1.23	3.08
embryonic pancreas cell line:1C3D3	10605-108F2	134.71	35.42	4.54	0.61	1.21	1.51	1.21	1.82	1.21	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	131.84	35.81	1.23	2.47	1.85	0.93	3.40	2.47	1.85	2.16
embryonic pancreas cell line:2C6	10603-108E9	85.38	31.52	1.31	2.63	0.00	0.00	1.31	1.31	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	100.22	18.77	1.68	6.37	2.35	1.01	4.69	1.68	1.01	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	101.31	56.18	1.09	0.00	4.71	0.72	2.90	0.91	0.00	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	71.56	8.84	0.80	0.32	0.32	0.96	1.93	0.32	0.64	0.00
epidermoid carcinoma cell line:A431	10426-106D3	197.08	23.79	3.22	1.33	1.11	2.22	0.44	1.22	0.89	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	124.28	19.47	0.77	0.55	0.99	0.55	1.21	1.87	0.99	1.10
epididymis, adult	10197-103E8	88.12	11.72	0.84	2.30	2.30	1.67	3.98	1.26	0.63	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	48.08	14.19	1.24	2.13	0.89	1.06	1.42	0.53	0.53	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	138.03	29.49	2.75	1.18	1.18	0.39	0.00	0.00	0.79	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	155.03	15.59	1.57	1.05	2.23	1.31	1.70	1.05	0.66	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	296.54	34.35	4.13	3.05	4.13	0.79	0.89	2.85	0.79	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	163.90	12.66	2.02	1.90	1.23	0.67	1.90	1.23	0.90	0.45
esophagus, adult, pool1	10015-101C6	136.23	23.04	0.85	1.38	2.12	0.96	2.34	1.38	0.64	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	146.78	51.60	3.51	4.63	4.38	1.63	4.76	3.26	0.25	4.13
eye - muscle inferior rectus, donor1	10272-104E2	50.71	9.66	0.00	7.24	9.66	4.83	0.00	0.00	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	115.73	12.63	0.00	4.21	0.00	0.00	2.10	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	34.23	0.00	0.00	0.00	8.93	1.49	4.46	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	96.31	9.17	1.15	0.00	3.44	0.00	3.44	1.15	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	164.69	14.57	1.46	13.12	0.00	0.00	1.46	2.91	2.91	1.46
eye, fetal, donor1	10054-101G9	83.64	8.14	0.76	3.56	3.05	1.02	1.53	1.27	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	93.73	16.16	0.38	1.15	1.92	0.64	0.77	1.03	0.51	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	113.25	25.40	1.42	2.14	1.90	0.47	2.85	1.66	0.71	1.42
frontal lobe, adult, pool1	10040-101F4	31.24	7.41	0.38	0.75	4.97	0.19	1.41	0.28	0.09	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	101.18	24.92	1.50	0.60	0.90	0.60	2.10	0.90	0.30	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	104.24	54.13	2.83	0.91	0.55	2.01	1.46	1.83	1.19	6.86
gall bladder, adult	10198-103E9	150.41	25.59	1.45	4.59	2.41	1.45	3.38	1.45	0.72	1.21
gamma delta positive T cells, donor1	11937-126A2	10.74	71.40	0.00	0.00	1.07	0.00	0.54	0.54	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	86.28	112.05	2.61	1.49	4.11	2.61	0.37	0.75	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	338.79	50.48	4.22	2.75	2.53	4.22	2.96	3.38	1.90	2.75
gastric adenocarcinoma cell line:MKN45	10612-108F9	232.68	92.45	4.84	2.51	1.16	1.16	2.71	2.90	0.97	1.35
gastric cancer cell line:AZ521	10549-107H9	97.39	27.38	1.48	0.98	2.95	0.82	1.64	1.97	0.33	1.48
gastric cancer cell line:GSS	10560-108A2	229.72	30.20	6.41	2.75	3.66	2.75	0.92	5.49	0.00	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	363.48	26.50	5.48	5.94	1.37	3.20	2.06	6.17	2.51	5.94
giant cell carcinoma cell line:LU65	10487-107B1	81.24	25.01	1.15	0.69	2.41	0.69	0.80	1.26	0.23	0.80
giant cell carcinoma cell line:Lu99B	10433-106E1	142.76	16.80	1.26	1.54	0.56	0.56	1.82	1.40	0.56	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	108.75	12.97	1.00	1.50	0.50	2.00	1.50	0.50	1.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	15.41	7.49	0.00	0.32	0.32	0.00	1.37	0.21	0.00	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	12.50	6.18	0.00	0.28	0.84	0.28	1.40	0.28	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	126.27	50.11	0.77	2.87	2.10	0.77	1.43	1.88	0.66	1.55
glioma cell line:GI-1	10413-106B8	220.54	24.60	1.17	1.46	0.59	1.76	1.76	2.34	1.76	4.39
globus pallidus - adult, donor10196	10175-103C4	65.60	2.19	0.00	1.46	4.37	0.73	1.46	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	97.64	14.40	0.98	4.15	2.69	0.49	2.20	0.49	0.00	0.73
globus pallidus, adult, donor10258	10367-105F7	30.12	2.74	0.00	1.37	0.00	0.00	1.37	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	90.60	5.86	2.13	0.53	1.07	1.07	0.53	1.60	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	85.65	41.60	2.45	4.89	7.34	0.00	4.89	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	54.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	99.31	52.27	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	37.76	7.36	0.00	0.64	1.60	0.64	1.60	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	42.70	7.80	1.84	5.05	0.46	0.46	2.30	0.46	0.00	2.30
hIPS +CCl2, biol_rep2	14384-156C1	49.38	9.15	0.00	1.37	0.00	0.00	0.91	0.00	0.00	3.20
hIPS +CCl2, biol_rep3	14385-156C2	58.61	7.73	1.29	0.64	0.00	0.64	0.64	0.00	0.00	1.29
hIPS, biol_rep1	14380-156B6	47.43	7.19	2.87	0.00	0.00	0.00	1.44	1.44	0.00	2.87
hIPS, biol_rep2	14381-156B7	56.24	7.54	0.69	0.69	0.69	0.69	2.06	1.37	1.37	0.00
hIPS, biol_rep3	14382-156B8	36.41	9.93	1.10	2.21	1.10	0.00	2.21	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	9.77	5.17	0.57	0.00	0.86	0.00	0.00	0.29	0.00	0.00
heart - mitral valve, adult	10205-103F7	106.13	12.56	1.49	3.59	2.39	1.79	1.79	0.30	0.00	0.90
heart - pulmonic valve, adult	10206-103F8	71.64	9.94	1.31	2.61	2.35	0.00	3.66	0.26	0.26	0.52
heart - tricuspid valve, adult	10207-103F9	252.29	22.48	2.50	6.66	4.16	0.83	1.67	0.83	0.83	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	151.00	16.53	2.45	2.65	2.86	1.22	2.45	1.22	1.02	1.02
heart, adult, diseased, donor1	10051-101G6	131.58	7.66	1.28	1.70	0.85	0.85	4.68	0.00	1.28	0.85
heart, adult, pool1	10016-101C7	254.12	14.49	2.53	2.53	0.69	0.46	2.76	1.38	0.92	1.15
heart, fetal, pool1	10046-101G1	124.96	7.19	0.82	4.52	0.62	0.92	2.88	0.92	0.21	1.75
hepatic mesenchymal tumor cell line:LI90	10778-110G4	54.92	8.95	0.00	0.62	0.93	0.93	0.62	0.62	0.00	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	52.32	17.84	1.19	8.32	4.76	1.19	4.76	3.57	2.38	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	102.43	13.59	1.33	5.97	2.43	0.33	3.76	0.99	0.66	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	96.61	15.05	1.09	8.13	0.97	0.24	2.91	0.61	0.73	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	114.90	15.97	1.41	7.28	1.62	0.71	3.13	1.11	0.91	1.11
hepatoma cell line:Li-7	10484-107A7	235.44	16.90	2.45	3.67	1.11	1.89	1.00	4.00	1.22	2.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	36.38	14.37	0.70	0.50	2.11	0.10	0.50	0.90	0.10	0.60
hippocampus - adult, donor10196	10169-103B7	95.58	2.84	0.00	4.73	5.68	0.00	2.84	0.95	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	68.37	14.70	1.43	2.65	5.71	0.00	3.67	0.61	0.00	1.22
hippocampus, adult, donor10258	10374-105G5	44.32	7.97	1.00	0.00	3.49	0.00	1.00	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	76.49	8.81	0.70	1.06	3.17	1.76	1.41	0.35	1.41	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	29.91	10.38	0.00	1.22	0.61	0.61	0.61	1.83	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	23.37	6.48	0.39	2.55	0.20	0.20	2.75	0.39	0.00	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	30.72	6.86	1.02	1.52	0.00	0.76	3.30	0.25	1.02	2.79
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.07	2.82	0.00	0.00	0.00	0.56	0.00	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.36	1.03	0.00	0.00	0.00	0.52	1.81	0.00	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.93	1.90	0.00	0.76	0.00	0.38	1.14	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	35.03	5.84	0.00	2.34	0.58	2.34	1.75	0.58	0.58	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	19.39	6.89	0.43	0.86	0.86	2.37	1.29	0.65	0.22	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.05	12.51	0.83	1.25	0.00	4.17	2.09	0.00	0.42	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	10.18	4.97	0.00	0.71	0.71	0.47	0.95	0.00	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	14.14	4.18	0.16	0.96	0.96	0.80	0.80	0.00	0.16	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	12.12	3.37	0.67	0.00	0.00	1.35	0.67	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.34	5.95	0.47	1.88	1.56	0.94	2.35	0.16	0.16	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	22.11	4.91	0.49	0.49	0.00	0.00	3.93	0.00	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	17.46	4.36	0.00	0.87	0.00	0.87	0.00	0.00	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	0.57	0.19	0.00	0.57	0.00	0.19	0.76	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	0.44	1.31	0.00	0.00	0.00	0.00	1.31	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	2.50	2.50	0.00	0.00	0.00	0.00	0.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.03	2.07	0.00	0.94	0.19	0.94	1.51	0.38	0.19	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.00	3.18	0.00	0.45	0.45	0.45	2.73	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.53	3.76	0.00	0.94	0.31	0.63	2.19	0.31	0.31	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7.84	3.43	0.00	0.00	0.33	0.65	1.63	0.16	0.16	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	12.48	3.48	0.00	0.00	0.29	0.58	2.03	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	14.95	5.98	0.00	0.90	0.30	0.90	1.79	0.00	0.30	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	20.88	9.42	0.18	2.40	0.55	0.92	3.14	0.92	0.00	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	26.53	9.98	0.29	3.14	1.14	0.29	2.57	0.29	1.14	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	22.05	6.94	0.41	2.45	0.41	1.63	3.67	0.00	0.41	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	6.34	3.52	0.00	0.00	0.35	0.70	2.11	0.00	0.00	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	7.60	3.17	0.00	0.95	0.00	0.63	1.27	0.00	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	7.26	3.63	0.61	0.30	0.00	0.61	2.42	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	23.79	5.17	0.52	2.07	0.52	2.59	1.55	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.95	7.97	0.66	1.33	0.66	0.00	0.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	17.96	4.87	0.00	1.03	0.26	0.77	1.28	0.77	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.71	4.09	0.00	0.77	0.51	0.51	1.02	0.00	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	13.63	6.82	0.76	2.27	0.00	0.76	0.76	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.13	5.04	0.34	0.34	1.01	1.34	1.34	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.19	9.42	0.48	1.69	1.69	0.97	5.07	0.24	0.00	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	25.85	13.37	0.00	2.67	0.45	0.89	2.67	0.89	0.45	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	29.27	8.29	0.00	3.90	0.98	0.49	3.41	0.98	0.00	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	4.58	2.14	0.31	0.00	0.00	0.92	1.22	0.31	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	3.97	1.32	0.00	0.33	0.00	0.33	1.65	0.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	33.93	3.83	0.00	0.55	0.55	2.19	0.55	0.00	0.55	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	29.31	5.79	0.00	0.72	0.72	2.90	3.26	0.36	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.98	2.14	0.36	2.14	1.07	2.14	2.14	0.00	0.71	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	0.00	0.00	1.19	0.00	0.00	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.89	4.88	0.00	0.27	0.81	0.27	1.22	0.00	0.14	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.70	2.69	0.27	0.81	0.54	0.00	1.35	0.00	0.00	1.08
immature langerhans cells, donor1	11904-125F5	8.48	3.15	0.24	0.00	0.48	0.00	0.48	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	37.23	2.38	0.00	0.79	0.00	0.00	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	42.02	6.25	0.57	1.14	4.16	0.47	1.70	0.28	0.19	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	210.37	22.44	0.65	2.93	0.98	0.33	6.18	0.33	0.65	0.65
kidney, adult, pool1	10017-101C8	123.26	13.12	1.20	1.20	0.70	0.70	1.50	0.40	0.80	0.40
kidney, fetal, pool1	10045-101F9	122.73	10.61	1.63	3.04	1.20	1.27	2.48	0.64	0.42	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	54.68	38.35	0.71	1.70	3.27	0.71	1.42	1.56	0.28	2.13
large cell lung carcinoma cell line:NCI-H460	10839-111E2	153.59	20.32	3.18	2.07	1.24	0.55	1.11	2.35	0.83	1.52
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	134.14	26.06	0.92	1.28	2.75	0.37	0.37	1.83	0.73	3.85
left atrium, adult, donor1	10079-102A7	38.68	9.26	0.00	1.09	2.18	0.00	2.18	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	101.64	5.06	0.51	4.05	0.51	0.51	1.01	2.53	0.51	1.01
leiomyoblastoma cell line:G-402	10721-110A1	41.59	4.65	0.82	3.56	0.55	0.55	0.82	1.37	0.27	1.64
leiomyoma cell line:10964C	10569-108B2	90.17	26.23	1.08	1.44	3.23	2.51	0.72	1.44	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	57.61	20.65	3.26	0.54	3.26	1.09	0.00	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	62.89	15.54	0.49	0.49	2.91	1.94	0.97	0.73	0.49	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	101.59	25.40	0.00	0.00	0.00	6.35	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	6.27	0.00	1.05	0.00	1.05	0.00	0.00	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	102.59	36.36	0.94	2.83	4.37	0.71	0.83	3.07	0.47	1.06
liposarcoma cell line:KMLS-1	10782-110G8	58.42	19.53	0.47	1.09	1.87	0.00	1.56	0.16	0.16	0.31
liposarcoma cell line:SW 872	10726-110A6	72.86	12.06	0.61	3.41	1.46	0.61	2.68	1.10	0.97	1.95
liver, adult, pool1	10018-101C9	553.60	15.56	5.19	6.32	0.49	4.70	1.46	2.27	2.11	0.65
liver, fetal, pool1	10086-102B5	127.94	8.47	1.88	6.58	0.94	2.82	1.88	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	54.10	4.08	0.44	3.94	1.17	0.29	1.17	0.44	0.87	0.44
locus coeruleus, adult, donor10252	10165-103B3	77.14	10.52	0.55	2.40	1.29	0.92	2.03	0.00	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	17.77	5.08	0.00	2.26	0.56	1.13	1.97	0.28	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	96.74	5.89	0.00	0.84	0.42	0.42	0.42	0.42	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	163.17	19.38	2.63	1.25	0.97	1.11	0.28	1.11	1.25	1.94
lung adenocarcinoma cell line:PC-14	10408-106B3	30.33	8.27	0.69	1.38	0.00	0.00	4.83	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	38.09	28.08	0.66	0.26	1.05	0.26	0.66	0.26	0.26	0.00
lung, adult, pool1	10019-101D1	476.17	36.74	5.67	5.55	1.77	4.13	1.42	2.60	2.01	1.06
lung, fetal, donor1	10068-101I5	508.31	24.55	4.57	9.99	3.42	2.00	1.43	0.57	1.43	2.85
lung, right lower lobe, adult, donor1	10075-102A3	323.04	36.66	4.58	6.87	2.75	14.66	4.12	1.83	2.75	0.46
lymph node, adult, donor1	10077-102A5	124.49	28.40	1.42	2.37	2.37	0.47	2.84	0.47	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	4.16	9.42	0.00	0.00	1.32	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.60	10.72	0.15	0.00	0.60	0.15	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	357.64	62.01	5.10	1.70	9.34	5.10	0.00	1.70	4.25	1.70
mature adipocyte, donor1	12231-129F8	693.96	36.41	12.43	5.33	0.89	6.22	1.78	2.22	5.77	0.44
mature adipocyte, donor2	12232-129F9	562.61	29.05	6.85	2.08	1.87	5.19	0.83	2.70	4.77	1.25
mature adipocyte, donor3	12233-129G1	696.49	22.52	8.53	7.82	2.84	5.22	0.47	0.95	5.22	0.71
mature adipocyte, donor4	12234-129G2	749.38	23.43	8.42	7.63	2.11	8.42	0.26	3.16	5.00	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	205.86	51.94	3.34	4.05	3.10	1.43	4.29	5.96	2.14	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	48.51	3.38	0.00	0.00	10.15	0.00	1.13	0.00	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	59.59	8.83	1.29	1.47	6.07	0.37	2.94	0.18	0.37	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	22.24	5.72	0.64	1.59	3.49	0.32	1.27	0.32	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	40.09	5.54	1.28	0.00	1.28	0.85	0.43	0.00	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	46.07	5.74	1.01	1.35	6.24	2.53	1.52	0.68	0.34	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	55.18	11.46	1.06	2.12	6.37	0.21	1.70	0.00	0.42	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	1.93	0.00	1.93	1.93	0.00	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	75.02	8.61	0.36	0.36	3.23	0.00	2.15	1.79	0.72	1.79
medulla oblongata - adult, donor10196	10174-103C3	86.31	6.49	1.95	3.24	0.65	0.00	2.60	1.95	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	91.95	12.69	0.77	2.32	1.86	0.77	2.48	0.15	0.15	0.62
medulla oblongata, adult, pool1	10038-101F2	77.06	8.90	1.39	2.04	0.73	0.33	2.12	0.57	0.65	0.73
medulla oblongata, newborn, donor10223	10361-105F1	73.26	5.21	2.78	0.69	0.00	1.04	2.43	0.00	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	119.78	11.73	0.89	1.77	1.33	0.66	1.77	1.33	0.22	4.21
medulloblastoma cell line:ONS-76	10759-110E3	63.95	8.44	0.24	0.98	1.10	0.00	1.83	0.37	0.24	0.86
melanoma cell line:COLO 679	10514-107E1	218.78	65.26	2.16	1.01	3.74	2.01	1.15	2.44	0.72	3.74
melanoma cell line:G-361	10465-106H6	125.69	39.63	2.71	0.00	2.44	2.17	1.63	1.36	1.90	3.80
meningioma cell line:HKBMM	10691-109F7	124.82	34.19	1.99	0.36	2.17	2.71	0.72	1.27	0.72	2.17
merkel cell carcinoma cell line:MKL-1	10843-111E6	1.76	3.52	0.00	0.88	0.00	0.00	0.00	0.00	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	4.15	2.07	0.00	0.00	1.04	0.00	0.26	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	129.50	17.95	1.23	2.30	1.69	1.07	1.38	0.61	0.92	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	165.24	27.63	1.82	2.18	1.82	1.64	0.36	0.55	1.27	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	163.16	11.18	0.83	0.00	1.66	0.00	1.66	0.83	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	162.95	15.59	1.12	0.56	1.40	1.12	0.98	0.98	1.12	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	160.99	14.06	1.16	0.96	0.96	0.58	0.00	0.77	1.93	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	208.92	23.60	2.08	1.39	1.39	1.39	0.00	1.39	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	218.83	43.60	3.26	1.54	1.72	1.37	2.23	2.06	1.54	1.72
mesenchymal precursor cell - cardiac, donor2	11753-123G7	207.95	19.90	2.07	1.73	1.50	1.15	1.27	1.04	1.84	1.15
mesenchymal precursor cell - cardiac, donor3	11754-123G8	104.65	16.98	1.46	0.93	0.80	0.40	0.53	0.53	0.66	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	116.54	13.50	0.95	1.35	0.81	1.35	0.81	0.81	0.68	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	109.54	14.37	0.57	2.13	0.71	0.43	1.28	0.57	0.85	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	322.11	51.71	5.27	1.32	1.65	1.65	3.29	2.31	5.27	3.29
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	136.85	9.69	0.83	1.25	1.25	0.55	0.69	0.42	0.14	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	112.75	9.43	0.70	1.75	0.70	1.40	1.05	0.35	0.00	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	92.49	16.13	1.02	0.82	2.25	0.20	0.82	0.20	0.20	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	129.40	22.65	3.95	2.16	2.52	0.72	0.36	0.72	1.80	2.52
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	233.59	16.76	2.48	1.86	1.34	1.14	0.52	0.62	1.86	1.86
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	127.68	30.55	3.42	1.60	0.68	1.82	0.91	0.91	4.33	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	88.11	7.13	0.84	0.84	0.84	0.00	0.84	0.42	1.68	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	195.91	15.84	2.54	1.64	0.60	0.60	0.30	0.90	1.05	1.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	155.19	25.47	0.96	1.84	1.31	1.14	1.58	1.23	1.05	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	376.63	24.30	5.15	2.95	1.10	1.10	0.74	2.21	2.95	2.58
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	101.87	21.46	2.58	1.14	0.57	1.43	0.00	0.00	1.43	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.84	8.42	0.00	0.84	0.42	0.00	0.42	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	119.65	32.88	0.46	0.91	3.65	0.00	1.37	1.37	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	115.36	30.95	0.51	0.77	4.35	1.53	0.51	1.28	1.02	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	121.72	26.96	1.57	0.52	3.14	1.05	0.79	0.79	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	132.79	36.66	2.16	0.62	5.24	0.92	0.92	0.31	0.92	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	123.56	30.36	1.18	0.71	3.53	1.41	1.65	1.41	0.71	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	148.24	26.06	1.35	1.02	3.05	1.35	0.34	0.00	0.34	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	169.37	31.04	1.57	1.18	1.18	0.39	0.79	0.39	1.18	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	163.11	31.97	0.93	0.93	2.32	0.46	0.46	1.85	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	255.25	29.42	2.31	0.58	2.60	2.31	1.15	0.87	0.87	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	237.60	27.44	1.78	1.78	3.12	0.89	0.89	0.89	1.34	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	239.39	28.36	1.92	3.12	2.40	1.68	1.20	1.44	2.16	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	124.67	19.80	0.73	1.47	1.47	0.00	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	189.31	30.21	1.34	1.68	2.01	1.34	1.34	1.01	2.35	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	187.90	26.61	2.05	1.64	2.05	2.05	2.05	0.00	0.82	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	271.48	29.21	3.87	1.29	1.29	1.72	0.86	1.29	1.72	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	284.38	16.41	0.00	2.73	2.73	8.20	0.00	0.00	5.47	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	263.41	25.82	0.00	5.16	0.00	10.33	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	257.56	22.41	4.22	0.97	1.30	2.60	1.62	2.27	4.87	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	285.18	32.01	2.91	1.45	0.00	1.45	0.00	0.00	4.36	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	271.87	38.91	3.73	1.60	1.60	2.13	1.07	0.00	1.07	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	278.86	27.80	3.27	1.64	2.45	3.27	2.45	1.64	3.27	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	281.43	27.99	3.89	3.50	4.28	3.89	0.78	0.39	2.72	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	270.74	25.18	4.20	2.10	4.20	2.10	0.00	0.00	4.20	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	249.36	25.83	2.98	4.97	0.99	0.00	0.99	0.00	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	238.36	52.44	0.00	9.53	4.77	4.77	0.00	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	244.30	21.35	3.56	2.37	2.37	1.19	1.19	0.59	3.56	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	185.21	18.28	0.00	0.00	3.66	0.00	1.22	1.22	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	297.58	27.05	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	174.81	24.07	2.53	3.17	1.90	0.63	0.00	0.00	1.90	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	134.86	10.35	1.38	2.07	0.69	1.03	1.38	0.34	1.72	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	150.44	17.19	0.00	4.30	0.00	2.15	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	139.71	19.96	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	175.64	20.66	0.00	0.00	0.00	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	149.13	25.26	0.00	3.26	2.44	0.81	0.81	1.22	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	132.67	16.68	0.79	3.18	1.59	0.79	0.00	1.59	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	119.67	14.74	1.18	2.36	1.18	0.59	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	124.06	16.21	0.94	1.56	2.49	0.62	0.00	0.31	1.56	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	144.36	12.03	0.00	1.34	1.34	1.34	0.00	0.00	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	114.72	10.64	4.73	3.55	0.00	3.55	0.00	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	107.86	10.27	0.00	5.14	5.14	2.57	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	111.52	13.08	0.00	3.44	1.38	0.69	0.69	0.00	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	190.01	23.26	2.97	1.48	1.98	0.49	0.99	1.98	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	148.04	21.31	1.12	0.00	1.12	4.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	188.27	20.99	5.72	2.54	1.27	1.91	1.27	1.27	2.54	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	333.67	27.81	10.88	3.63	2.82	2.82	0.40	2.42	4.84	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	348.89	37.07	8.72	4.36	0.00	8.72	2.18	2.18	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	338.30	31.68	8.87	1.27	0.00	1.27	0.00	2.53	3.80	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	247.00	44.91	4.25	4.25	6.07	4.25	0.61	1.82	3.03	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	302.77	36.15	4.52	0.00	4.52	4.52	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	224.04	48.60	4.94	4.12	8.24	0.82	0.82	2.47	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	114.69	19.45	0.99	3.17	2.58	1.19	0.79	0.40	1.79	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	141.80	17.52	0.97	3.89	3.57	0.32	1.30	0.97	0.32	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	134.46	23.43	2.04	4.07	3.06	2.04	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	32.50	6.96	0.77	0.77	0.77	0.00	2.32	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	41.81	20.08	0.47	0.24	0.24	0.94	0.24	1.42	0.71	2.13
mesothelioma cell line:ACC-MESO-4	10494-107B8	186.50	18.07	1.16	1.62	0.46	2.55	2.09	1.16	2.09	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	141.03	21.37	0.00	4.27	4.27	0.00	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	114.05	19.73	1.95	0.41	1.13	1.03	0.82	0.82	0.00	0.51
mesothelioma cell line:Mero-25	10850-111F4	293.68	61.96	4.54	9.31	3.63	0.45	1.13	1.59	3.18	5.90
mesothelioma cell line:Mero-41	10851-111F5	163.55	24.20	0.49	1.47	0.00	0.00	1.47	0.24	1.47	0.98
mesothelioma cell line:Mero-48a	10852-111F6	25.69	11.29	0.00	0.22	0.66	0.00	0.66	0.22	0.00	1.33
mesothelioma cell line:Mero-82	10853-111F7	328.24	66.75	1.84	6.57	3.15	2.10	1.31	3.42	2.10	4.99
mesothelioma cell line:Mero-83	10854-111F8	32.17	9.19	0.51	0.68	0.51	0.17	0.51	0.17	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	103.13	10.62	1.01	2.02	0.25	0.76	1.26	0.76	1.01	0.00
mesothelioma cell line:Mero-95	10856-111G1	200.62	43.69	2.48	5.59	3.73	0.62	1.24	0.62	1.45	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	94.92	19.38	1.33	0.00	0.17	0.83	1.33	0.33	0.33	1.16
mesothelioma cell line:NCI-H226	10846-111E9	90.86	23.35	0.90	1.09	1.09	0.36	0.72	0.18	0.72	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	52.27	17.08	0.85	0.51	1.02	0.51	3.42	0.34	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	22.90	10.18	0.00	0.51	0.51	0.00	1.53	0.00	0.00	0.51
mesothelioma cell line:No36	10857-111G2	44.04	11.74	0.33	0.00	1.63	0.00	2.28	0.65	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	137.64	24.39	2.44	0.81	0.81	0.54	1.08	1.63	0.54	0.81
migratory langerhans cells, donor1	11901-125F2	3.84	9.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	6.84	12.21	0.12	0.00	0.12	0.24	0.37	0.00	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	5.38	5.38	0.00	0.18	0.18	0.00	0.18	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	166.50	54.20	2.61	4.24	2.29	5.88	1.31	2.94	2.29	5.55
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	164.67	6.99	1.06	4.03	0.85	2.12	1.06	1.06	1.27	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	87.54	35.24	1.15	2.30	1.84	0.46	0.46	1.15	0.46	1.15
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	4.00	2.66	0.00	0.00	0.76	0.00	0.19	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	83.34	50.26	0.37	0.92	2.40	0.37	0.74	1.29	0.37	0.37
myeloma cell line:PCM6	10474-106I6	137.97	145.68	0.59	0.59	5.93	0.59	0.00	0.00	0.40	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.20	4.06	0.00	0.51	1.52	0.00	1.01	0.00	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	346.58	37.27	2.75	1.96	1.57	0.78	3.14	1.96	2.55	2.75
nasal epithelial cells, donor1, tech_rep1	12226-129F3	220.73	50.25	2.56	0.78	1.45	2.34	0.78	1.23	0.56	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	246.14	54.49	2.28	0.74	1.03	1.91	0.51	1.91	0.74	0.37
nasal epithelial cells, donor2	12227-129F4	228.52	45.82	3.86	2.21	1.10	2.21	0.55	2.76	1.10	3.31
neuroblastoma cell line:CHP-134	10508-107D4	217.18	17.25	2.07	6.67	2.07	0.92	2.30	0.92	1.15	9.43
neuroblastoma cell line:NB-1	10539-107G8	22.64	15.90	0.00	1.31	2.43	0.37	1.87	0.19	0.56	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	1091.77	22.99	5.90	28.05	2.53	8.65	1.90	3.37	3.80	5.90
neuroblastoma cell line:NH-12	10555-107I6	87.58	16.96	0.37	3.54	1.12	0.75	3.17	1.49	0.93	4.10
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	164.16	6.17	2.37	7.12	0.24	2.37	0.24	0.95	1.66	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	472.13	31.36	8.39	21.38	5.38	10.14	2.69	3.80	3.48	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	82.92	11.27	0.81	8.25	1.21	0.20	1.41	0.20	0.40	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	90.91	5.09	2.54	12.08	1.91	1.27	5.72	0.00	1.91	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	47.64	14.11	0.53	0.27	3.73	0.00	1.33	0.53	0.80	0.80
neutrophil PMN, donor1	12133-128D9	74.37	89.25	0.00	14.87	14.87	0.00	29.75	0.00	14.87	14.87
neutrophil PMN, donor2	12137-128E4	79.68	53.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	132.59	151.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	23.85	24.52	0.17	1.18	1.52	0.17	0.00	0.85	0.68	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	56.84	14.41	0.00	4.80	0.80	0.00	2.40	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	221.22	26.61	3.85	4.49	4.81	5.13	3.21	1.60	1.28	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	84.08	25.49	1.58	1.58	0.26	2.10	0.53	1.05	0.53	0.53
nucleus accumbens, adult, pool1	10037-101F1	50.90	6.84	0.28	1.41	4.87	0.28	1.78	0.56	0.28	0.28
occipital cortex - adult, donor10196	10172-103C1	43.27	4.12	0.00	2.06	12.36	0.00	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	76.48	14.22	0.81	2.68	10.20	0.27	1.88	0.00	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	79.34	5.82	1.46	2.55	2.91	0.73	1.09	0.00	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	17.58	6.30	0.00	1.05	7.35	0.52	1.57	0.26	0.52	0.79
occipital lobe, fetal, donor1	10073-102A1	1.72	2.15	0.00	0.00	1.29	0.43	0.86	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	33.35	7.88	0.71	0.47	6.47	0.24	1.42	0.24	0.16	1.02
olfactory region, adult	10195-103E6	25.79	6.88	0.19	0.96	3.82	0.38	1.15	0.19	0.19	0.38
optic nerve, donor1	10277-104E7	28.01	2.00	0.00	4.00	2.00	0.00	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	213.46	37.59	2.96	1.25	2.28	2.05	3.19	1.25	0.57	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	129.69	13.60	1.65	0.69	0.41	1.37	0.69	1.24	0.41	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	69.59	21.84	0.68	1.02	1.35	1.35	0.68	0.68	0.85	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	178.69	57.52	0.81	0.81	3.12	0.46	1.96	0.69	0.92	1.62
osteoclastoma cell line:Hs 706.T	10704-109H2	127.88	21.46	1.18	0.88	1.47	1.47	1.47	1.18	1.18	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	80.35	25.23	0.00	0.93	1.87	1.87	0.93	0.00	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	55.14	15.06	1.27	2.12	0.42	0.64	1.48	1.27	0.42	0.64
ovary, adult, pool1	10020-101D2	244.23	16.25	1.66	8.04	1.92	2.01	3.76	0.79	1.48	2.45
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	66.36	9.53	0.55	0.73	1.83	0.55	0.55	0.92	1.28	1.47
pancreas, adult, donor1	10049-101G4	54.56	25.40	0.94	2.82	4.70	0.00	3.76	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	102.03	18.73	1.12	1.40	1.12	1.12	5.59	1.40	1.40	3.35
papillary adenocarcinoma cell line:8505C	10437-106E5	117.88	45.48	0.85	0.51	1.53	2.90	2.04	2.21	0.68	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	143.39	18.21	2.32	1.82	0.17	0.99	0.99	2.15	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	40.54	6.41	0.46	1.56	5.31	0.09	1.74	0.27	0.18	0.82
parietal cortex, adult, donor10258	10373-105G4	41.10	12.48	0.73	0.00	3.67	1.47	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	50.79	6.58	0.00	0.00	5.64	0.00	0.00	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	70.97	10.55	0.57	2.00	9.98	0.29	2.28	0.00	0.29	0.86
parietal lobe, adult, pool1	10034-101E7	45.38	6.43	0.88	1.32	5.55	0.09	2.64	0.09	0.09	0.53
parietal lobe, fetal, donor1	10072-101I9	0.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	71.78	7.10	1.50	1.87	1.12	0.37	0.37	1.87	1.50	1.12
parotid gland, adult	10199-103F1	151.08	26.52	0.62	0.62	8.63	0.00	2.47	0.00	0.00	0.00
penis, adult	10200-103F2	100.98	12.35	0.54	2.69	6.45	3.22	2.15	0.54	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	116.95	26.96	2.42	7.62	3.72	0.93	0.93	1.49	2.23	1.67
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	124.86	52.60	2.33	2.19	5.10	0.73	1.75	1.60	1.02	2.19
pineal gland - adult, donor10196	10179-103C8	25.80	3.23	0.00	1.29	0.65	0.65	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	24.28	7.11	0.00	1.78	0.59	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	8.15	3.76	0.63	0.63	0.00	0.00	2.51	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	57.67	5.06	1.01	3.04	1.01	0.00	2.02	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	75.57	7.30	0.52	0.00	3.13	0.52	2.08	0.00	0.00	1.56
pituitary gland, adult, donor10258	10378-105G9	13.62	5.96	0.00	0.85	0.85	0.00	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	547.51	25.48	3.66	1.18	0.75	3.33	3.12	2.26	2.15	1.18
plasma cell leukemia cell line:ARH-77	10840-111E3	17.22	11.12	0.40	0.00	0.26	0.00	0.13	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	142.88	23.19	1.56	0.93	1.25	2.02	1.71	1.09	1.71	0.78
pons, adult, pool1	10033-101E6	28.75	4.65	0.34	0.52	0.95	0.17	0.95	0.17	0.09	0.26
postcentral gyrus, adult, pool1	10032-101E5	34.96	8.19	0.26	1.13	5.32	0.26	2.44	0.52	0.09	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	18.82	43.92	0.00	0.00	6.27	2.09	12.55	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	66.10	66.10	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	136.05	15.73	2.18	1.17	1.75	1.17	1.46	0.73	1.02	1.31
prostate cancer cell line:PC-3	10439-106E7	38.30	14.52	0.00	0.91	1.27	0.36	1.63	0.00	0.18	0.91
prostate, adult, pool1	10022-101D4	166.69	22.58	1.09	3.54	3.08	1.45	3.17	0.73	0.91	1.09
putamen, adult, donor10196	10176-103C5	100.09	6.85	0.71	3.54	5.67	0.47	1.18	0.24	1.18	0.00
putamen, adult, donor10252	10152-102I8	84.31	5.88	0.00	1.96	13.73	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	38.25	9.84	0.00	0.00	3.28	0.00	1.09	0.00	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	34.79	7.25	1.21	1.69	5.56	0.24	1.93	0.24	0.24	0.24
putamen, newborn, donor10223	10365-105F5	56.22	3.00	1.50	0.00	0.00	0.75	0.75	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	96.88	20.95	1.16	0.29	1.16	1.45	1.45	0.29	0.29	0.87
rectum, fetal, donor1	10067-101I4	9.74	18.08	0.00	5.56	4.17	0.00	4.17	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	58.72	23.53	0.85	0.21	1.70	0.85	1.27	0.85	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	96.10	9.94	1.24	1.24	0.00	2.07	2.90	0.41	1.24	0.41
retina, adult, pool1	10030-101E3	134.39	19.98	1.69	3.48	2.09	1.19	5.86	0.70	0.60	1.39
retinoblastoma cell line:Y79	10475-106I7	16.63	5.20	0.00	3.12	2.08	0.26	2.86	1.30	0.00	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	18.20	9.84	0.12	0.25	1.11	0.00	0.86	0.25	0.00	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	47.80	13.22	0.84	1.41	0.56	0.28	2.81	0.28	0.00	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	86.40	9.09	0.00	2.27	2.27	0.00	1.52	0.00	0.76	2.27
salivary acinar cells, donor1	11771-123I7	180.79	12.95	2.43	1.46	0.49	2.10	0.97	1.29	0.65	0.65
salivary acinar cells, donor2	11772-123I8	208.18	13.22	1.65	2.62	1.79	0.96	1.93	1.10	0.55	0.55
salivary acinar cells, donor3	11773-123I9	141.68	14.57	3.97	3.31	1.32	0.66	2.65	0.00	1.32	0.00
salivary gland, adult, pool1	10093-102C3	145.28	29.74	0.57	0.57	5.15	0.00	2.29	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	167.36	27.99	2.53	3.12	1.69	1.10	2.02	1.94	1.43	3.37
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	153.88	29.62	2.23	2.35	1.76	1.06	2.12	2.94	1.29	2.23
seminal vesicle, adult	10201-103F3	94.17	24.34	0.00	0.53	3.70	0.53	2.65	0.00	3.17	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	101.79	22.83	1.46	1.94	2.67	0.97	0.73	0.49	0.97	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	367.89	16.36	4.28	3.52	1.51	3.27	2.77	4.28	4.03	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	61.22	12.04	0.00	0.00	2.01	1.00	3.01	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	575.70	32.64	7.52	5.10	0.40	2.96	5.51	3.36	3.49	5.37
signet ring carcinoma cell line:Kato III	10436-106E4	247.91	32.50	2.21	3.43	1.99	2.21	0.77	2.32	0.66	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	93.93	6.97	1.42	0.52	0.65	0.65	0.52	0.77	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	122.01	3.55	0.00	3.55	4.97	2.84	1.42	1.42	2.84	0.71
skeletal muscle, adult, pool1	10023-101D5	908.05	23.51	10.67	8.04	2.88	8.04	4.68	5.64	3.60	5.28
skeletal muscle, fetal, donor1	10066-101I3	9.05	4.02	0.00	1.01	1.01	0.00	2.01	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	135.70	6.79	0.00	13.57	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	118.67	15.15	0.63	1.89	1.89	2.52	0.63	0.00	3.16	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	7.34	9.67	0.00	0.33	1.67	0.00	2.00	0.00	0.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	55.79	23.01	0.63	1.89	3.47	0.95	4.10	0.63	0.32	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	97.72	10.79	0.58	0.58	0.96	1.93	3.08	0.96	0.77	1.54
small cell lung carcinoma cell line:LK-2	10541-107H1	79.28	27.69	0.82	0.33	1.48	1.32	0.82	0.82	0.16	2.14
small cell lung carcinoma cell line:NCI-H82	10842-111E5	36.19	4.99	0.32	1.77	0.32	0.00	3.54	1.29	0.80	5.79
small cell lung carcinoma cell line:WA-hT	10562-108A4	137.07	69.30	0.22	1.53	10.68	1.53	1.96	0.44	0.22	1.74
small intestine, adult, pool1	10024-101D6	188.36	33.68	1.43	2.39	2.03	3.22	2.03	0.36	0.60	0.24
small intestine, fetal, donor1	10064-101I1	31.45	10.56	0.49	1.72	1.23	0.25	0.98	0.25	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	127.20	103.61	1.03	1.03	7.69	4.10	1.54	0.00	1.54	1.03
smooth muscle, adult, pool1	10048-101G3	81.67	11.11	0.52	3.62	3.10	0.26	3.36	0.26	0.26	0.52
somatostatinoma cell line:QGP-1	10781-110G7	57.09	34.57	1.07	0.80	4.82	0.27	4.29	1.61	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	71.57	4.13	1.61	3.21	2.52	0.92	0.46	0.69	1.84	1.84
spinal cord, adult, donor10252	10159-103A6	104.09	9.86	1.97	2.37	2.76	0.39	1.97	0.79	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	26.29	8.99	0.00	0.00	2.08	0.00	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	21.95	9.76	0.61	0.61	2.44	0.61	1.22	0.00	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	45.46	2.76	1.38	0.00	0.46	0.00	0.92	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	65.12	24.34	1.05	0.15	1.94	0.15	0.30	1.05	0.45	0.30
spleen, adult, pool1	10025-101D7	301.66	28.86	3.41	1.76	0.88	2.86	0.66	1.43	0.77	0.55
spleen, fetal, pool1	10044-101F8	299.63	24.87	2.30	3.18	1.51	2.86	1.83	1.19	1.03	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	4.14	7.76	0.00	0.00	0.10	0.00	0.00	0.21	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	139.37	23.35	1.71	1.33	1.14	0.76	1.71	2.09	0.76	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	198.84	32.50	3.84	1.75	1.75	0.70	3.15	3.15	1.05	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	160.67	70.37	1.95	0.39	3.13	0.78	0.00	2.74	1.56	3.52
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	172.10	36.24	0.90	4.05	4.73	1.58	2.81	1.35	1.01	3.26
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	142.75	28.80	0.85	2.12	2.97	1.27	2.97	0.42	0.00	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.08	35.54	0.85	0.00	1.69	0.00	1.69	1.27	0.00	0.42
stomach, fetal, donor1	10062-101H8	37.38	5.34	1.07	8.54	3.20	1.07	2.14	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	108.24	19.94	1.71	1.14	2.85	1.14	0.57	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	95.54	9.14	1.04	1.45	2.28	0.62	1.45	0.00	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	24.31	6.72	0.52	0.00	0.52	0.52	2.59	0.00	0.52	1.03
substantia nigra, newborn, donor10223	10358-105E7	57.23	7.77	2.12	1.41	0.00	0.71	1.41	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	7.57	9.63	0.00	0.00	1.15	0.00	1.83	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	42.30	8.22	0.42	1.02	6.02	0.59	2.12	0.34	0.17	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	1.42	0.71	0.00	0.00	0.00	0.00	0.71	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.07	2.20	0.44	0.00	0.44	0.88	1.76	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	194.45	17.46	0.70	0.35	1.40	2.44	1.05	1.05	0.70	1.05
tenocyte, donor2	11765-123I1	268.20	17.55	1.14	0.76	4.20	1.91	1.14	0.38	0.76	1.14
tenocyte, donor3	11768-123I4	117.87	20.39	0.37	0.74	3.34	0.74	0.00	0.00	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	34.67	5.27	0.51	0.85	0.17	0.51	2.72	1.02	0.68	2.21
teratocarcinoma cell line:NCR-G1	10798-110I6	5.86	4.32	0.00	0.62	0.46	0.00	1.54	0.15	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	26.04	9.30	0.00	1.70	1.24	0.15	2.79	0.00	0.15	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	47.73	20.18	1.02	1.78	0.51	0.63	2.16	1.65	0.38	2.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	155.81	20.04	3.40	4.92	0.00	1.13	6.43	1.89	2.27	6.43
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	58.46	47.44	0.65	0.65	1.42	0.44	0.98	0.76	0.00	3.60
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	50.16	5.54	0.00	1.30	0.00	1.30	0.98	0.00	0.65	1.63
testis, adult, pool1	10026-101D8	178.35	15.46	1.07	3.44	1.18	1.83	3.76	0.75	0.64	1.83
testis, adult, pool2	10096-102C6	33.83	9.02	0.45	0.45	0.90	0.90	2.71	0.00	0.00	0.45
thalamus - adult, donor10196	10168-103B6	107.09	5.52	1.10	5.52	1.10	1.10	3.31	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	82.20	13.91	1.72	2.03	2.66	0.63	1.41	1.41	0.31	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	76.98	1.54	0.00	3.08	0.00	0.00	1.54	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.47	4.94	0.16	0.82	1.65	0.49	1.48	0.00	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	24.16	3.45	0.00	0.00	1.15	0.00	0.58	0.58	0.58	0.00
throat, adult	10209-103G2	153.05	17.73	0.50	2.75	3.00	6.49	1.75	0.50	1.00	2.00
throat, fetal, donor1	10061-101H7	58.20	2.13	0.30	2.74	2.44	0.61	1.22	0.30	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	17.89	12.72	0.00	0.99	1.79	0.00	0.79	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	15.11	18.59	0.00	0.50	1.09	0.30	0.89	0.00	0.10	0.00
thymus, fetal, pool1	10043-101F7	133.41	19.64	1.04	1.56	1.45	1.66	0.62	0.42	0.10	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	214.33	36.17	3.19	1.06	0.66	1.46	2.26	2.66	1.99	3.32
thyroid carcinoma cell line:TCO-1	10783-110G9	110.77	52.94	1.54	1.26	5.87	0.84	1.54	1.54	1.12	2.24
thyroid, adult, pool1	10028-101E1	402.18	24.63	1.77	5.51	2.71	2.89	7.09	1.03	1.21	1.03
thyroid, fetal, donor1	10060-101H6	70.66	3.43	0.00	3.43	3.69	0.26	4.75	0.26	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	18.48	0.00	6.16	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	170.01	11.86	2.09	1.86	2.09	3.02	1.63	0.70	1.40	0.70
tongue, fetal, donor1	10059-101H5	103.65	9.85	0.39	2.36	2.36	0.00	3.55	1.58	0.00	0.00
tonsil, adult, pool1	10047-101G2	105.59	24.84	0.60	0.90	1.10	1.30	1.10	0.40	0.10	0.10
trachea, adult, pool1	10029-101E2	369.16	23.23	3.03	3.52	1.23	3.19	2.04	1.15	1.64	0.74
trachea, fetal, donor1	10058-101H4	88.48	9.23	1.54	3.85	4.62	1.54	1.54	0.38	0.00	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	75.46	13.82	0.35	1.06	1.77	0.00	1.06	0.35	0.35	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	230.80	16.51	1.42	0.71	1.01	1.11	1.52	1.82	0.51	1.52
transitional-cell carcinoma cell line:JMSU1	10492-107B6	254.62	57.35	4.70	3.29	2.19	3.60	1.57	3.29	1.88	2.66
tridermal teratoma cell line:HGRT	10694-109G1	26.64	3.81	0.00	1.90	0.00	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	142.04	85.24	2.45	1.95	4.15	1.35	2.45	2.12	1.10	2.29
umbilical cord, fetal, donor1	10057-101H3	87.63	4.17	0.00	2.09	0.00	0.00	2.09	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	146.91	16.21	0.00	2.90	1.54	1.19	4.95	0.34	0.68	1.19
uterus, fetal, donor1	10055-101H1	48.63	8.19	0.00	4.10	3.58	0.00	0.00	0.51	0.00	0.00
vagina, adult	10204-103F6	204.85	23.91	1.94	5.82	2.58	0.65	3.23	0.65	0.65	0.65
vein, adult	10191-103E2	119.90	17.76	0.88	1.97	2.63	0.66	1.32	0.88	0.66	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.61	8.55	0.27	0.00	0.00	0.00	0.27	0.00	0.00	0.00